<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">86105</article-id><article-id pub-id-type="doi">10.7554/eLife.86105</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title>Conditional blastocyst complementation of a defective Foxa2 lineage efficiently promotes the generation of the whole lung</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-304321"><name><surname>Miura</surname><given-names>Akihiro</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1217-7220</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-304322"><name><surname>Sarmah</surname><given-names>Hemanta</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9374-9269</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-304323"><name><surname>Tanaka</surname><given-names>Junichi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-304324"><name><surname>Hwang</surname><given-names>Youngmin</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5190-6062</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-304325"><name><surname>Sawada</surname><given-names>Anri</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-304326"><name><surname>Shimamura</surname><given-names>Yuko</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-332307"><name><surname>Otoshi</surname><given-names>Takehiro</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-332308"><name><surname>Kondo</surname><given-names>Yuri</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-272324"><name><surname>Fang</surname><given-names>Yinshan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-332306"><name><surname>Shimizu</surname><given-names>Dai</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-304328"><name><surname>Ninish</surname><given-names>Zurab</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-304329"><name><surname>Suer</surname><given-names>Jake Le</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-304330"><name><surname>Dubois</surname><given-names>Nicole C</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-240776"><name><surname>Davis</surname><given-names>Jennifer</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-304331"><name><surname>Toyooka</surname><given-names>Shinichi</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-301239"><name><surname>Wu</surname><given-names>Jun</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9863-1668</contrib-id><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-304332"><name><surname>Que</surname><given-names>Jianwen</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con17"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-249303"><name><surname>Hawkins</surname><given-names>Finn J</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con18"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-79232"><name><surname>Lin</surname><given-names>Chyuan-Sheng</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="con19"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-152034"><name><surname>Mori</surname><given-names>Munemasa</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7283-7198</contrib-id><email>mm4452@cumc.columbia.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con20"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00hj8s172</institution-id><institution>Columbia Center for Human Development and Division of Pulmonary, Allergy, Critical Care, Department of Medicine, Columbia University Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02pc6pc55</institution-id><institution>Department of Thoracic, Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences</institution></institution-wrap><addr-line><named-content content-type="city">Okayama</named-content></addr-line><country>Japan</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/010b9wj87</institution-id><institution>The Pulmonary Center and Department of Medicine, Boston University School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/010b9wj87</institution-id><institution>Center for Regenerative Medicine, Boston University and Boston Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a9tmd77</institution-id><institution>Department of Cell, Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai</institution></institution-wrap><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00cvxb145</institution-id><institution>Department of Pathology, University of Washington</institution></institution-wrap><addr-line><named-content content-type="city">Seattle</named-content></addr-line><country>United States</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00t9vx427</institution-id><institution>Department of Molecular Biology, University of Texas Southwestern Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">Dallas</named-content></addr-line><country>United States</country></aff><aff id="aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00hj8s172</institution-id><institution>Bernard and Shirlee Brown Glaucoma Laboratory, Department of Pathology and Cell Biology, College of Physicians and Surgeons, Columbia University Irving Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Morrisey</surname><given-names>Edward E</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00b30xv10</institution-id><institution>University of Pennsylvania</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Eisen</surname><given-names>Michael B</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01an7q238</institution-id><institution>University of California, Berkeley</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>20</day><month>10</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e86105</elocation-id><history><date date-type="received" iso-8601-date="2023-01-11"><day>11</day><month>01</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2023-10-19"><day>19</day><month>10</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2022-11-02"><day>02</day><month>11</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.10.31.514628"/></event></pub-history><permissions><copyright-statement>© 2023, Miura et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Miura et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-86105-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-86105-figures-v2.pdf"/><abstract><p>Millions suffer from incurable lung diseases, and the donor lung shortage hampers organ transplants. Generating the whole organ in conjunction with the thymus is a significant milestone for organ transplantation because the thymus is the central organ to educate immune cells. Using lineage-tracing mice and human pluripotent stem cell (PSC)-derived lung-directed differentiation, we revealed that gastrulating Foxa2 lineage contributed to both lung mesenchyme and epithelium formation. Interestingly, Foxa2 lineage-derived cells in the lung mesenchyme progressively increased and occupied more than half of the mesenchyme niche, including endothelial cells, during lung development. <italic>Foxa2</italic> promoter-driven, conditional Fgfr2 gene depletion caused the lung and thymus agenesis phenotype in mice. Wild-type donor mouse PSCs injected into their blastocysts rescued this phenotype by complementing the Fgfr2-defective niche in the lung epithelium and mesenchyme and thymic epithelium. Donor cell is shown to replace the entire lung epithelial and robust mesenchymal niche during lung development, efficiently complementing the nearly entire lung niche. Importantly, those mice survived until adulthood with normal lung function. These results suggest that our Foxa2 lineage-based model is unique for the progressive mobilization of donor cells into both epithelial and mesenchymal lung niches and thymus generation, which can provide critical insights into studying lung transplantation post-transplantation shortly.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>lung generation</kwd><kwd>conditional blastocyst complementation</kwd><kwd>lung mesenchyme precursors</kwd><kwd>mesendoderm</kwd><kwd>whole organ generation</kwd><kwd>thymus generation</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100017540</institution-id><institution>NHLBI Division of Intramural Research</institution></institution-wrap></funding-source><award-id>1R01 HL148223-01</award-id><principal-award-recipient><name><surname>Mori</surname><given-names>Munemasa</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000005</institution-id><institution>U.S. Department of Defense</institution></institution-wrap></funding-source><award-id>PR190557</award-id><principal-award-recipient><name><surname>Mori</surname><given-names>Munemasa</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000005</institution-id><institution>U.S. Department of Defense</institution></institution-wrap></funding-source><award-id>PR191133</award-id><principal-award-recipient><name><surname>Mori</surname><given-names>Munemasa</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>JSPS202080340</award-id><principal-award-recipient><name><surname>Miura</surname><given-names>Akihiro</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100008732</institution-id><institution>The Uehara Memorial Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Miura</surname><given-names>Akihiro</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The Foxa2 lineage-based organ generative strategy allows us to establish a unique paradigm for the simultaneous generation of functional whole lungs and thymus, which can be applied to future transplantation therapy.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Whole organ generation to treat various intractable diseases has long been challenging (<xref ref-type="bibr" rid="bib19">Hackett et al., 2010</xref>; <xref ref-type="bibr" rid="bib28">Kemter et al., 2020</xref>; <xref ref-type="bibr" rid="bib38">Ott et al., 2010</xref>; <xref ref-type="bibr" rid="bib41">Petersen et al., 2010</xref>; <xref ref-type="bibr" rid="bib54">Wang, 2019</xref>). Organ bioengineering strategy based on recellularizing tissue-specific progenitors into the decellularized scaffolds, induced pluripotent stem cell (iPSC)-derived organoids, or 3D bioprinters are the next-generation tissue transplant therapies (<xref ref-type="bibr" rid="bib18">Guyette et al., 2014</xref>; <xref ref-type="bibr" rid="bib34">Kotton and Morrisey, 2014</xref>; <xref ref-type="bibr" rid="bib41">Petersen et al., 2010</xref>; <xref ref-type="bibr" rid="bib50">Tian et al., 2021</xref>). Even with these techniques, however, the mammalian lung is one of the most challenging organs to replicate because of its anatomical complexity and cellular diversity. It contains hundreds of airway branches and a thin micron-sized alveolar layer of inflated and well-vascularized alveoli composed of billions of cells from more than 50 different cell types (<xref ref-type="bibr" rid="bib11">Crapo et al., 1982</xref>; <xref ref-type="bibr" rid="bib34">Kotton and Morrisey, 2014</xref>; <xref ref-type="bibr" rid="bib47">Stone et al., 1992</xref>; <xref ref-type="bibr" rid="bib51">Travaglini et al., 2020</xref>). Donor organs for lung transplantation are in short supply worldwide, but the technology does not exist to generate whole lungs composed of tissue-specific epithelial and mesenchymal cells, including endothelial cells. Lungs grow fully only through natural lung development.</p><p>During development, lung epithelial and mesenchymal precursors interact to initiate an elaborate developmental program of organogenesis that includes specification, pattern formation, progenitor cell expansion, and differentiation. The lung epithelial cells are derived from the foregut, definitive endoderm (DE) derivatives, classically labeled by Sox17 and Forkhead Box A2 (Foxa2) (<xref ref-type="bibr" rid="bib17">Green et al., 2011</xref>; <xref ref-type="bibr" rid="bib26">Huang et al., 2014</xref>). Multiple genetic studies using Sonic Hedgehog (Shh) Cre lineage-tracing mice have also shown that the entire Nkx2-1+ lung and tracheal epithelial primordium arises from Shh<sup>+</sup> DE (<xref ref-type="bibr" rid="bib6">Cardoso and Kotton, 2008</xref>; <xref ref-type="bibr" rid="bib10">Christodoulou et al., 2011</xref>; <xref ref-type="bibr" rid="bib22">Harris et al., 2006</xref>; <xref ref-type="bibr" rid="bib27">Kadzik and Morrisey, 2012</xref>; <xref ref-type="bibr" rid="bib49">Tian et al., 2011</xref>; <xref ref-type="bibr" rid="bib55">Weaver et al., 1999</xref>; <xref ref-type="bibr" rid="bib57">Xing et al., 2008</xref>).</p><p>The lung mesenchyme primordium is derived from Wnt2<sup>+</sup> Isl1<sup>+</sup> cardiopulmonary progenitors (CPP) (<xref ref-type="bibr" rid="bib39">Peng et al., 2013</xref>). CPP is the derivative of Osr1<sup>+</sup> Nkx6-1<sup>+</sup>Barx1<sup>−</sup> Wnt4<sup>low</sup> foregut lung mesoderm that arises from lateral plate mesoderm (LPM) (<xref ref-type="bibr" rid="bib21">Han et al., 2020</xref>). While DE and LPM arise from primitive streaks (PS) during gastrulation, the exact lineage origin of LPM has been a complete mystery.</p><p>Mesendoderm is a bipotent transitional state between the PS and nascent mesoderm labeled by Mixl1, Pdgfrα, and Brachyury (T) during gastrulation that can give rise to both DE and mesoderm (<xref ref-type="bibr" rid="bib23">Hart et al., 2002</xref>; <xref ref-type="bibr" rid="bib48">Tada et al., 2005</xref>). Although it was speculated that mesendoderm might form LPM and DE, there have been no conclusive genetic studies on whether mesendoderm gives rise to both lung epithelium and mesenchyme. Pdgfrα is expressed in the epiblast-derived mesendoderm, the primitive endoderm (PrE), and its extra-embryonic endoderm derivatives, such as parietal and visceral endoderm, around E5.5–E7.5. Foxa2 plays a pivotal role in alveolarization and airway goblet cell expansion (<xref ref-type="bibr" rid="bib53">Wan et al., 2004</xref>), while there was a significant knowledge gap regarding Foxa2 lineage during lung development.</p><p>Blastocyst complementation (BC) has been proposed as a promising option for tissue-specific niche complementation (<xref ref-type="bibr" rid="bib7">Chen et al., 1993</xref>). This unique technology has been further developed into intra- and interspecies organ generations such as kidney, pancreas, thymus, and blood vessels (<xref ref-type="bibr" rid="bib20">Hamanaka et al., 2018</xref>; <xref ref-type="bibr" rid="bib31">Kobayashi et al., 2010</xref>; <xref ref-type="bibr" rid="bib52">Usui et al., 2012</xref>; <xref ref-type="bibr" rid="bib58">Yamaguchi et al., 2017</xref>). However, co-generation of targeted organs and thymus has never been reported, while educating host immune cells for organ transplantation is critical to avoid graft-versus-host disease (GvHD) post-transplantation (<xref ref-type="bibr" rid="bib5">Bos et al., 2022</xref>). The production of entire organs, including tissue-specific epithelium and mesenchyme, including endothelium, was also tricky because the origin of pulmonary endothelium seems similar to the other organs. Unfortunately, even with BC, the lungs produced were non-functional and very inefficient, and in addition, the chimeric lungs contained a substantial amount of host-derived tissue (<xref ref-type="bibr" rid="bib30">Kitahara et al., 2020</xref>; <xref ref-type="bibr" rid="bib56">Wen et al., 2021</xref>). Previously, we established the conditional blastocyst complementation (CBC) approach, which targets specific lineages complemented by donor PSCs (<xref ref-type="bibr" rid="bib36">Mori et al., 2019</xref>). Using lineage-specific drivers of lung endoderm in CBC avoids the effects of genetic manipulation in non-target organs for the generation of empty organ niches that lead to functional chimeric lung generation (<xref ref-type="bibr" rid="bib36">Mori et al., 2019</xref>). However, most of the lung mesenchyme and endothelium were still derived mainly from the host cells, which was the severe limitation of CBC (<xref ref-type="bibr" rid="bib36">Mori et al., 2019</xref>). Given that the CBC approach targeted endodermal lungs, we speculated that this limitation was due to a significant gap in our knowledge of the origin of all lung cell types, especially pulmonary mesenchyme, including endothelium. In particular, the complementation of endothelium is a critical issue for overcoming hyperacute rejection after lung transplantation. To overcome this critical issue, we explored the origin and the program of whole lung epithelium and mesenchyme, the major components of the lung.</p><p>We hypothesized that targeting a single lung precursor lineage may facilitate the designing of the entire lung generation. Our Foxa2-based CBC methodology diverges from our prior Shh-based CBC model (<xref ref-type="bibr" rid="bib36">Mori et al., 2019</xref>), which targeted the earliest lung precursor lineage, mesendoderm, allowing us to label entire lung epithelium and about 20% of mesenchyme, enough for leading to generating the whole lungs efficiently. Accidentally, we also found that Fgfr2 deficiency in the Foxa2 lineage caused a thymus agenesis phenotype, which was simultaneously rescued by injecting pluripotent stem cells (PSCs) into the blastocysts. Our Foxa2 lineage-based CBC approach results in the highly efficient co-generation of functional lungs and thymus, offering new avenues for exploring the future of autologous lung transplantation.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Pdgfrα<sup>+</sup> lineage during gastrulation gives rise to the entire lung mesenchyme</title><p>To determine the origin of LPM and pulmonary endothelium that leads to the whole lung generation, we performed lung mesenchyme precursor lineage-tracing analysis using <italic>Pdgfra<sup>CreERT2/+</sup>; Rosa<sup>tdTomato/+</sup></italic> mice. At E5.5 tamoxifen (Tm) administration, E14.5 lung immunostaining analysis showed that the entire lung mesenchyme was labeled with tdTomato but not in the epithelium (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). E12.5 morphometric analyses showed an extremely high proportion of lung mesenchyme labeling with tdTomato (<xref ref-type="fig" rid="fig1">Figure 1B, C</xref>). Among three embryos at E12.5, two showed 100% tdTomato labeling for lung mesenchyme markers, while one showed about 60% labeling in the mesenchyme (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Sma<sup>+</sup> airway smooth muscle cells (86.9% ± 22.7), Pdgfrα<sup>+</sup> lung mesenchyme (78.7% ± 36.9), and VE-cadherin<sup>+</sup> endothelium (82.5% ± 30.4) were labeled with tdTomato (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). These results indicate that the whole lung mesenchyme originates from the Pdgfrα lineage around early-to-mid-streak-stage embryos before LPM formation. In addition, the Pdgfrα lineage labels 20.5% ± 18.3 the lung epithelium (<xref ref-type="fig" rid="fig1">Figure 1B</xref>, arrows), suggesting that the contribution of the Pdgfrα lineage to the lung endoderm is limited. It indicates that the Pdgfrα lineage faces challenges in rendering the entire lung niches effectively defective across both the endoderm and mesoderm for CBC-mediated lung generation.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Pdgfrα lineage during gastrulation is the origin of the entire pulmonary mesenchyme.</title><p>(<bold>A</bold>) Left: Schematic of tamoxifen administration. Right: Representative immunofluorescence (IF)-confocal imaging of E14.5 <italic>Pdgfra<sup>CreERT2/+</sup>; Rosa26<sup>tdTomato/+</sup></italic> lineage tracing mouse lungs. Scale bars = 100 μm. (<bold>B</bold>) Tamoxifen administration at E5.5 and analyzed at E12.5. Pdgfrα-lineage-driven tdTomato (red) labeled the part of lung epithelium (arrows) and entire lung mesenchyme, including Sma<sup>+</sup> airway smooth muscle cells, Pdgfrα<sup>+</sup> mesenchyme, and VE-cadherin<sup>+</sup> capillaries. Enlarged box: dotted box. Scale bar = 50 μm. (<bold>C</bold>) Quantification of <italic>Pdgfra<sup>CreERT2/+</sup>; Rosa26<sup>tdTomato/+</sup></italic> lineage labeling (<italic>n</italic> = 3 per group, each plot showed different embryos). Error bars represent mean ± standard deviation (SD). (<bold>D–F</bold>) Representative IF-confocal imaging of E6.5 <italic>Foxa2<sup>Cre/+</sup>; Rosa26<sup>tdTomato/+</sup></italic> embryo. E-cadherin or Sox2 indicates epiblast. (<bold>D</bold>) Mixl1 (red) expression represents primitive streak (PS) (yellow dotted area). (<bold>E</bold>) Foxa2-lineage (red) marked a broader region of the distal component of the anteriolarizing PS (arrows), expressing Foxa2 protein (arrowhead). (<bold>F</bold>) Foxa2-lineage (red)-labeled Pdgfrα (green) expressing mesendoderm (arrows). Scale bars = 50 μm. (<bold>G</bold>) Quantification of Foxa2-lineage labeling in PS (<italic>n</italic> = 3 per group, each plot showed different embryos). Error bars represent mean ± SD.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Quantification of <italic>Pdgfra<sup>CreERT2/+</sup>; Rosa26<sup>tdTomato/+</sup></italic> lineage labeling by immunofluorescence (IF) morphometric analysis.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-86105-fig1-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>Quantification of Foxa2-lineage labeling in PS by immunofluorescence (IF) morphometric analysis.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-86105-fig1-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86105-fig1-v2.tif"/></fig></sec><sec id="s2-2"><title>Foxa2 lineage labels Pdgfrα<sup>+</sup> mesendoderm niche during mouse development</title><p>Single-cell RNA-seq (scRNA-seq) analysis using Foxa2-Venus fusion protein reporter mice indicated that the Foxa2 lineage might give rise to LPM and DE (<xref ref-type="bibr" rid="bib45">Scheibner et al., 2021</xref>).</p><p>Given that Foxa2 and Pdgfrα are expressed during the conversion from mesendoderm to mesenchyme (<xref ref-type="bibr" rid="bib2">Artus et al., 2010</xref>; <xref ref-type="bibr" rid="bib33">Kopper and Benvenisty, 2012</xref>; <xref ref-type="bibr" rid="bib45">Scheibner et al., 2021</xref>; <xref ref-type="bibr" rid="bib48">Tada et al., 2005</xref>), we used Foxa2-lineage-tracing mice (<italic>Foxa2<sup>Cre/+</sup>; Rosa<sup>tdTomato/+</sup></italic>) (<xref ref-type="bibr" rid="bib25">Horn et al., 2012</xref>) to determine whether the Foxa2 lineage would label Mixl1<sup>+</sup> or Pdgfrα<sup>+</sup> mesendoderm during gastrulation. We found that Mixl1<sup>+</sup> within the PS region (<xref ref-type="fig" rid="fig1">Figure 1D</xref>, yellow dotted line), 87.3% ± 5.26 expressed Pdgfrα protein (<xref ref-type="fig" rid="fig1">Figure 1E, F</xref>). While the Foxa2 lineage appeared in the distal compartment of Mixl1 weakly positive mesendoderm (<xref ref-type="fig" rid="fig1">Figure 1E</xref>, arrows) at the anterior primitive streak besides the Foxa2 protein-expressing DE (<xref ref-type="fig" rid="fig1">Figure 1E</xref>, arrowheads), those Foxa2 lineage-driven tdTomato labeled 27.5% ± 1.15 of mid-streak PS and 18.6% ± 8.93 in the Pdgfrα<sup>+</sup> mesendoderm of PS around mid-streak-stage embryos (<xref ref-type="fig" rid="fig1">Figure 1F, G</xref>, arrows). These results suggest that the Foxa2 lineage-labeled Pdgfrα<sup>+</sup> cells are the distal component of mesendoderm, most likely the derivative of posterior epiblasts since Foxa2 is expressed only in the posterior epiblasts before gastrulation (<xref ref-type="bibr" rid="bib45">Scheibner et al., 2021</xref>). Based on our Foxa2-lineage-tracing data on early embryogenesis, we further examined whether Foxa2 lineage would label lung mesenchyme.</p></sec><sec id="s2-3"><title>Foxa2-lineage labeling increased during lung development, leading to occupy the entire lung epithelium and half of the lung mesenchyme, including lung endothelium</title><p>Foxa2-lineage-tracing mice (<italic>Foxa2<sup>Cre/+</sup>; Rosa<sup>tdTomato/+</sup></italic>) faithfully target Nkx2-5<sup>+</sup> cardiac progenitors associated with the origin of Wnt2<sup>+</sup> Isl1<sup>+</sup> CPP (<xref ref-type="bibr" rid="bib3">Bardot et al., 2017</xref>; <xref ref-type="bibr" rid="bib39">Peng et al., 2013</xref>) lung mesenchyme. However, there was no conclusive evidence of whether Foxa2 lineage can give rise to Wnt2<sup>+</sup> Isl1<sup>+</sup> CPP (<xref ref-type="bibr" rid="bib3">Bardot et al., 2017</xref>; <xref ref-type="bibr" rid="bib39">Peng et al., 2013</xref>). Using the Foxa2-lineage-tracing mice, we found from immunostaining that the Foxa2-lineage labeled the entire lung epithelium and most of the lung mesenchyme at E16.5 (<xref ref-type="fig" rid="fig2">Figure 2A–C</xref>). Quantitative analyses by flow cytometry (FCM) in the E14.5 developing lungs of Foxa2-lineage-tracing mice showed that Foxa2-lineage labeled almost the entire lung epithelium (93.3% ± 2.00) and about 20% of lung mesenchyme (24.2% ± 5.51), including endothelial cells (16.8% ± 5.12) (<xref ref-type="fig" rid="fig2">Figure 2D, E</xref>), which was a similar proportion of the Foxa2-lineage-labeled Pdgfrα<sup>+</sup> mesendoderm (<xref ref-type="fig" rid="fig1">Figure 1E–G</xref>). Contrary to expectations, Foxa2-lineage-labeled cells increased dramatically throughout lung development (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). In adulthood, the Foxa2-lineage labeling reached about 99.97% ± 0.06 in lung epithelium, 51.3% ± 1.72 in lung mesenchyme, and 60.0% ± 8.44 in lung endothelial cells, with more than twofold change in the lung endothelium, compared with E14.5 (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). Morphometric analysis of immunostaining further confirmed the Foxa2-lineage labeling of each mesenchyme marker. Foxa2 lineage marked about 30–40% of E14.5 multiple cell types of lung mesenchyme such as Sma<sup>+</sup> smooth muscle cells (31.9% ± 9.16), VE-cadherin<sup>+</sup> (39.3% ± 12.5), or Pecam1<sup>+</sup> (36.9% ± 10.4) endothelial cells, Pdgfrβ<sup>+</sup> pericytes of the pulmonary arteries and pulmonary veins (41.4% ± 10.5), and WT1<sup>+</sup> mesothelial cells (31.9% ± 23.7) (<xref ref-type="fig" rid="fig2">Figure 2F, G</xref>). Interestingly, no clear Foxa2 protein level expression was observed in the mesenchyme of the embryonic lungs at E14.5 and E18.5 (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>), consistent with previously reported Foxa2 protein expression patterns (<xref ref-type="bibr" rid="bib53">Wan et al., 2004</xref>). However, the LungMAP deposited single-cell RNA-seq database analysis showed a sporadic Foxa2 transcriptional expression pattern in developing lung mesenchyme, particularly in proliferating endothelium, on E15.5 and E17.5 (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). We confirmed <italic>Foxa2</italic> transcriptional expression in lung mesenchyme by in situ hybridization analysis on E18.5 (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C, D</xref>). The expression was detected mostly in tdTomato positive but low frequency in the negative cells, which indicates that lung mesenchyme spontaneously expressed <italic>Foxa2</italic> at a transcriptional level and turned on tdTomato during lung development. We also sorted the cell fraction of CD45<sup>−</sup>CD31<sup>−</sup>EPCAM<sup>−</sup>tdTomato<sup>+</sup> and CD45<sup>−</sup>CD31<sup>−</sup>EPCAM<sup>−</sup>tdTomato<sup>−</sup> from developing lung mesenchyme at E18.5. We observed a slight increase in the relative expression of <italic>Foxa2</italic> in the tdTomato<sup>+</sup> fraction of embryonic lung mesenchyme, most likely contributing to the labeling in the Foxa2-lineage-tracing mice (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1E</xref>). These results suggest pulmonary mesenchymal progenitor cells turned on Foxa2 expression slightly at the mRNA level rather than the protein level, which led to a gradual increase in Foxa2 lineage labeling. Furthermore, tdTomato<sup>+</sup> endothelial cells were found to have a slightly higher proliferative capacity than tdTomato<sup>−</sup> cells (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). These results suggest that Foxa2 lineage<sup>+</sup> pulmonary mesenchymal appeared during lung development, and lineage labeling gradually increased compared to Foxa2<sup>-</sup> lung mesenchyme progenitors throughout lung development.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Foxa2-lineage gradually increased during lung development and labeled the entire lung epithelium and half of the mesenchyme.</title><p>(<bold>A–C</bold>) Immunofluorescence (IF)-confocal imaging of E16.5 <italic>Foxa2<sup>Cre/+</sup>; Rosa<sup>tdTomato/+</sup></italic> embryonic lung: (<bold>A</bold>) Foxa2-lineage (red)-labeled E-cadherin<sup>+</sup> lung epithelium (green) entirely and Pfgfrβ<sup>+</sup> mesenchyme (cyan) partially. (<bold>B</bold>) Foxa2-lineage partially labeled VE-cadherin<sup>+</sup> capillary (ca) (enlarged box, blue arrowhead). (<bold>C</bold>) Foxa2-lineage-labeled Pdgfrβ<sup>+</sup> smooth muscle cells of the pulmonary artery (pa) (enlarged box, white arrowhead) and pulmonary vein (pv, yellow arrowhead). Scale bars (<bold>A</bold>), (<bold>B</bold>), and (<bold>C</bold>) = 200, 100, and 100 μm, respectively. (<bold>D, E</bold>) Representative histograms and the graphs of flow cytometry (FCM) quantitative analyses for CD31<sup>−</sup>Epcam<sup>+</sup> lung epithelium, CD31<sup>−</sup>Epcam<sup>−</sup> mesenchyme, and CD31<sup>+</sup>Epcam<sup>−</sup> endothelium at E14.5, E18.5, P0, and 4 weeks adult (<italic>n</italic> = 4, 6, 7, and 3, independent biological replicates, respectively) of <italic>Foxa2<sup>Cre/+</sup>; Rosa<sup>tdTomato/+</sup></italic> mouse lungs. The gradual increase of % tdTomato<sup>+</sup> lineage labeling in both lung mesenchyme and endothelium. Statistical analysis: one-way analysis of variance (ANOVA) with the Tukey post hoc test; statistically significant if **p &lt; 0.01, ***p &lt; 0.001, ****p &lt; 0.0001. Error bars represent mean ± standard deviation (SD). (<bold>F</bold>) Representative IF-confocal imaging of E14.5 <italic>Foxa2<sup>Cre/+</sup>; Rosa<sup>tdTomato/+</sup></italic> embryonic lungs. tdTomato labeled entirely with lung epithelial markers Nkx2-1 (left) but a relatively low proportion of mesenchyme (Pdgfrβ: middle and Sma: right). Scale bar = 50 µm. (<bold>G</bold>) Graphs: The morphometric analysis: % of E14.5 Foxa2-lineage labeling in Nkx2-1<sup>+</sup> epithelium, Pdgfrβ<sup>+</sup> mesenchyme, Sma<sup>+</sup> airway smooth muscle, VE-Cadherin<sup>+</sup> capillaries, Pecam1<sup>+</sup> arteries, or WT1<sup>+</sup> mesothelium (<italic>n</italic> = 3 per biological replicates, 5 fields per group). Error bars represent mean ± SD.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Flow cytometry (FCM) quantitative analyses for CD31-Epcam<sup>+</sup> lung epithelium, CD31<sup>−</sup>Epcam<sup>−</sup> mesenchyme, and CD31<sup>+</sup>Epcam<sup>−</sup> endothelium at E14.5, E18.5, P0, and 4 weeks adult.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-86105-fig2-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>The morphometric analysis: % of E14.5 Foxa2-lineage labeling with each lung marker.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-86105-fig2-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86105-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Foxa2-lineage gradually increased in the mesenchyme and endothelial cells during mouse lung development.</title><p>(<bold>A</bold>) Representative immunofluorescence (IF)-confocal imaging of E14.5 and E18.5 mouse embryonic lungs. Foxa2 (green) was expressed in lung epithelial cells labeled by E-cadherin (red) but not in E-cadherin negative lung mesenchymal area. Scale bar = 50 µm (<bold>B</bold>) Single-cell analysis of mouse LungMAP. <italic>Foxa2</italic> expression was observed in lung mesenchyme and endothelium in E15.5 and E17.5 (arrows). (<bold>C, D</bold>) Representative IF and in situ hybridization-confocal imaging of E18.5 mouse embryonic lungs. Dotted lines: enlarged image. <italic>Foxa2</italic> mRNA was expressed in lung epithelial cells and lung mesenchyme. Most of the <italic>Foxa2</italic> mRNA expression was colocalized with tdTomato. Scale bars (left, right) = 50 µm, 20 µm. (<bold>E</bold>) Graphs: <italic>Foxa2</italic> qPCR for tdTomato<sup>+</sup> (tdT<sup>+</sup>) or tdTomato<sup>−</sup> (tdT<sup>−</sup>) CD45<sup>−</sup>CD31<sup>−</sup>EPCAM<sup>−</sup> mesenchymal cells and CD45<sup>−</sup>CD31<sup>−</sup>EpCAM<sup>+</sup> epithelial cells sorted by Fluorescence-activated cell sorting (FACS) from E18.5 Foxa2-lineage-tracing mice (<italic>n</italic> = 3, each biological replicate). (<bold>F</bold>) Flow cytometry quantitative analyses: 5-ethynyl-2-deoxyuridine (EdU) labeling cells in CD31<sup>+</sup>Epcam<sup>−</sup> endothelium at E14.5 and E18.5 (<italic>n</italic> = 6, each independent biological replicate, respectively) of <italic>Foxa2<sup>Cre/+</sup>; Rosa<sup>tdTomato/+</sup></italic> lungs. Statistical analysis: paired Student’s <italic>t</italic>-test, significance at *p &lt; 0.05, ns: non-significant. Error bars represent mean ± standard deviation (SD).</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Foxa2 qPCR for tdTomato<sup>+</sup> (tdT<sup>+</sup>) or tdTomato<sup>−</sup> (tdT<sup>−</sup>) CD45<sup>−</sup>CD31<sup>−</sup>EPCAM<sup>−</sup> mesenchymal cells and CD45<sup>−</sup>CD31<sup>−</sup>EpCAM<sup>+</sup> epithelial cells.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-86105-fig2-figsupp1-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2s1sdata2"><label>Figure 2—figure supplement 1—source data 2.</label><caption><title>Flow cytometry quantitative analyses: EdU labeling cells in CD31<sup>+</sup>Epcam<sup>−</sup> endothelium at E14.5 and E18.5 of <italic>Foxa2<sup>Cre/+</sup>; Rosa<sup>tdTomato/+</sup></italic> lungs.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-86105-fig2-figsupp1-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86105-fig2-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-4"><title>Co-development of endodermal and mesodermal lung progenitors derived from MXIL1<sup>+</sup> PDGFRα<sup>+</sup> FOXA2<sup>+</sup> mesendoderm in the directed differentiation protocol using hiPSC</title><p>To determine whether Foxa2 or Pdgfrα mesendoderm is an evolutionarily well-conserved niche that can give rise to both pulmonary endoderm and mesoderm, we modified a previously reported protocol to establish a pulmonary endoderm–mesoderm co-developmentally directed differentiation protocol (<xref ref-type="bibr" rid="bib8">Chen et al., 2017</xref>; <xref ref-type="bibr" rid="bib16">Gotoh et al., 2014</xref>; <xref ref-type="bibr" rid="bib24">Hawkins et al., 2017</xref>; <xref ref-type="bibr" rid="bib26">Huang et al., 2014</xref>; <xref ref-type="bibr" rid="bib32">Konishi et al., 2016</xref>; <xref ref-type="fig" rid="fig3">Figure 3A</xref>). With this optimized protocol, various hiPSC lines efficiently induced a lung bud-like appearance, indicated by NKX2-1 expression in lung epithelial cells (<xref ref-type="bibr" rid="bib16">Gotoh et al., 2014</xref>; <xref ref-type="bibr" rid="bib32">Konishi et al., 2016</xref>). On day 6, NKX2-1<sup>+</sup> cells emerged in bud structure (<xref ref-type="fig" rid="fig3">Figure 3B</xref>, asterisk, and S2A). On day 10, TBX4<sup>+</sup> lung mesenchyme arose and surrounded the NKX2-1<sup>+</sup>SOX9<sup>+</sup> lung epithelium (<xref ref-type="fig" rid="fig3">Figure 3B, C</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A, B</xref>). Morphometric analysis of budding structure with lung markers revealed the heterogeneity of bud structures (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). The budding morphology appeared 2.8% ±0 .90 per field on day 6 and progressively increased its proportion and reached around 57.4% ± 9.10. Among the developing bud structures, NKX2-1 was initially turned on 44.5% ± 6.41 at day 6, but the proportion progressively increased, and NKX2-1 was positive on the 95.9% ± 3.98 of day 15 budding structures. It indicates that the bud-like structure preceded the lung cell fate specification. Interestingly, we found SOX9 expression in the 27.9% ± 13.1 of NKX2-1+ lung bud cells on day 8, but it dramatically increased and reached nearly 100% positive on day 15 (98.4% ± 1.98). This result indicated that NKX2-1 precedes the expression of SOX9. The proportion of TBX4<sup>+</sup> cells progressively increased in non-budding areas during the differentiation (48.2% ± 3.17). The qPCR kinetics analyses across the time point further supported the appearance of lung mesenchyme, represented by LPM marker expression peaked on days 6–8: <italic>OSR1</italic>, <italic>FGF10</italic>, <italic>BMP4</italic>, and <italic>PDGFRA</italic> (<xref ref-type="bibr" rid="bib35">Loh et al., 2016</xref>), and smooth muscle cell markers peaked on days 8–10: <italic>ACTA2</italic> and <italic>PDGFRΒ</italic> (<xref ref-type="bibr" rid="bib21">Han et al., 2020</xref>), and CPP markers peaked on days 8–12; <italic>ISL1</italic>, <italic>WNT2</italic>, <italic>FOXF1</italic>, and <italic>TBX4</italic> (<xref ref-type="bibr" rid="bib29">Kishimoto et al., 2020</xref>; <xref ref-type="bibr" rid="bib39">Peng et al., 2013</xref>), peaked on days 10–14 simultaneously with pulmonary epithelial markers, <italic>NKX2-1</italic> and <italic>CPM</italic> (<xref ref-type="fig" rid="fig3">Figure 3D</xref>; <xref ref-type="bibr" rid="bib16">Gotoh et al., 2014</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Co-development of endodermal and mesodermal lung progenitors derived from MXIL1<sup>+</sup> PDGFRα<sup>+</sup> FOXA2<sup>+</sup> mesendoderm in the directed differentiation protocol using hiPSC.</title><p>(<bold>A</bold>) Schematic culture protocol of hiPSC-derived endodermal and mesodermal lung progenitor cell co-differentiation. (<bold>B</bold>) Representative phase-contrast images of the directed differentiation time course. Bud structure appeared on day 6 (asterisk). Scale bars = 100 μm. (<bold>C</bold>) Representative immunofluorescence (IF)-confocal imaging of differentiating hiPSCs at day 14 culture. Lung epithelium (NKX2-1), distal lung bud epithelium (SOX9), mesenchyme (TBX4), and nucleus (Hoechst) markers. The budding structures expressed SOX9 and NKX2-1 (asterisk), and monolayer cells expressed TBX4. Scale bar = 100 μm. (<bold>D</bold>) RT-PCR analyses of lung mesenchyme and epithelium markers in time course according to the protocol shown in (<bold>A</bold>). Each plot showed a different biological experiment (<italic>n</italic> = 3 independent experiments). Error bars represent mean ± standard deviation (SD). (<bold>E</bold>) Flow cytometry (FCM)-based protein kinetic analyses during definitive endoderm (DE) and lateral plate mesoderm (LPM) induction; MIXL1 expression preceded compared to PDGFRα or FOXA2. FOXA2 appearance in the subset of the PDGFRα<sup>+</sup> population (red asterisk) (<italic>n</italic> = 3 independent experiments). (<bold>F</bold>) Representative IF imaging of 36-hr-cultured hiPSCs. Scale bar = 100 μm. (<bold>G</bold>) Schematic summary of FCM analysis. (<bold>H</bold>) Quantitative Reverse Transcription Polymerase Chain Reaction (qRT-PCR) analyses further confirmed the preceded <italic>MIXL1</italic> induction and subsequent expression of <italic>PDGFRα</italic> and <italic>FOXA2</italic>. All graphs: Data normalized by undifferentiated induced pluripotent stem cells (iPSCs). Each plot showed a different biological experiment (<italic>n</italic> = 3 independent experiments). Error bars represent mean ± SD.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>qRT-PCR analyses of lung mesenchyme and epithelium markers in time course of directed differentiation.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-86105-fig3-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title>qRT-PCR analyses of mesendoderm markers in time course of directed differentiation.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-86105-fig3-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86105-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Endodermal and mesodermal lung progenitors develop together in the directed differentiation using hiPSC.</title><p>(<bold>A, B</bold>) Representative immunofluorescence (IF) imaging of days 6, 8, 10, 12, and 15 directed differentiations. Bud structure gradually formed larger colonies with NKX2-1 (green) and SOX9 (red) expression over time. In contrast, nuclear TBX4<sup>+</sup> cells (magenta) emerged in the area of non-bud structures over time. Scale bar = 100 µm. (<bold>C, D</bold>) Graphs: Quantification of morphometric analyses (<bold>A</bold>), % bud structure area, % NKX2-1<sup>+</sup> or SOX9<sup>+</sup> cells in bud structure, and % SOX9<sup>+</sup> cells in NKX2-1<sup>+</sup> cells or NKX2-1<sup>+</sup> cells in SOX9<sup>+</sup> cells, % TBX4<sup>+</sup> cells in non-bud structure. Each plot showed different experimental replicates (5 fields per each group). Error bars represent mean ± standard deviation (SD).</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>% GFP in CD31<sup>+</sup>Epcam<sup>−</sup> lung endothelium analyzed by flow cytometry.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-86105-fig3-figsupp1-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3s1sdata2"><label>Figure 3—figure supplement 1—source data 2.</label><caption><title>% GFP in CD45<sup>+</sup> hematopoietic cells analyzed by flow cytometry.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-86105-fig3-figsupp1-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86105-fig3-figsupp1-v2.tif"/></fig></fig-group><p>In this differentiation protocol, NKX2-1<sup>+</sup> lung endoderm and WNT2<sup>+</sup>TBX4<sup>+</sup> lung mesoderm were derived from the anteroventral endoderm and mesoderm at day 15 after Activin-mediated DE and LPM induction, respectively (<xref ref-type="bibr" rid="bib8">Chen et al., 2017</xref>; <xref ref-type="bibr" rid="bib26">Huang et al., 2014</xref>). During PS induction from days 0 to 3, cell surface markers of PDGFRα and EPCAM and intracellular FOXA2 and MIXL1 kinetics were analyzed by FCM every 12 hr (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). Briefly, 12 hr after the Activin induction, more than 60% of the EPCAM<sup>+</sup>PDGFRα<sup>−</sup> PS first turned on MIXL1, the mesendoderm marker (<xref ref-type="bibr" rid="bib23">Hart et al., 2002</xref>; <xref ref-type="bibr" rid="bib48">Tada et al., 2005</xref>). Subsequently, the epithelial–mesenchymal transition occurred 24 hr later, as represented by the PDGFRα induction in EPCAM<sup>+</sup>MIXL1<sup>+</sup> mesendoderm. After 36 hr, more than 90% of MIXL1<sup>+</sup>EPCAM<sup>+</sup> mesoderm cells expressed PDGFRα. At the same time, expression of FOXA2 appeared in some of those mesoderm cells (<xref ref-type="fig" rid="fig3">Figure 3E, F</xref>, asterisk). Thereafter, PDGFRα expression decreased, and 72 hr later, mutual FOXA2 induction appeared when EPCAM<sup>+</sup>FOXA2<sup>+</sup> DE and EPCAM<sup>−</sup>FOXA2<sup>−</sup> LPM were presented (<xref ref-type="fig" rid="fig3">Figure 3G</xref>). The dynamics of MIXL1, PDGFRα, and FOXA2 were further revealed by qPCR analysis (<xref ref-type="fig" rid="fig3">Figure 3H</xref>). These results suggest that PDGFRα<sup>+</sup> and FOXA2<sup>+</sup> lineage are redundant but distinct stages of mesendoderm development. It indicates that mesendoderm is the lung precursor niche, with short-time window, contributing to both endodermal and mesodermal-derived lungs, evolutionally conserved across mouse development and human-directed differentiation.</p></sec><sec id="s2-5"><title>Foxa2-driven Fgfr2 conditional knockout showed a lung agenesis phenotype</title><p>Since the Foxa2-lineage<sup>+</sup> mesendoderm forms endodermal and mesodermal lung niches (<xref ref-type="fig" rid="fig3">Figure 3E</xref>), and the lung mesenchyme lineage was progressively labeled and reached more than 50% by Foxa2 lineage (<xref ref-type="fig" rid="fig2">Figure 2E</xref>), we investigated the Foxa2-lineage-based CBC strategy. To explore this possibility, we analyzed Foxa2-driven Fgfr2 conditional knockout mouse phenotype (<italic>Foxa2<sup>Cre/+</sup>; Fgfr2<sup>flox/flox</sup></italic>, hereafter, <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO). Mitotic signaling via Fgfr2 is required for both lung epithelium and mesenchyme, and systemic knockout mice of Fgf10 or Fgfr2 exhibit a phenotype of lung agenesis (<xref ref-type="bibr" rid="bib1">Arman et al., 1999</xref>; <xref ref-type="bibr" rid="bib12">De Langhe et al., 2006</xref>; <xref ref-type="bibr" rid="bib13">De Moerlooze et al., 2000</xref>; <xref ref-type="bibr" rid="bib46">Sekine et al., 1999</xref>). Based on the results of Foxa2-lineage tracing and the need for Fgfr2 signaling, it was predicted that <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO mice would be used to generate vacant niches in both lung epithelium and mesenchyme. We did not observe differences in the apparent gross morphology of embryos in <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO mice however, they exhibited a lung agenesis phenotype and died at birth by respiratory distress (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A, B</xref>). We did not observe agenesis phenotype in other major endodermal organs, such as the liver, esophagus, pancreas, and intestine (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). This is because those organs were Foxa2-lineage labeled (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>), but Fgfr2 is not critical for their organ formation. We also confirmed that kidney, glandular stomach, hair follicles, tooth bud, and limbs were preserved, which is known to form organ defective phenotype in the Fgfr2 systemic knockout (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>; <xref ref-type="bibr" rid="bib1">Arman et al., 1999</xref>; <xref ref-type="bibr" rid="bib12">De Langhe et al., 2006</xref>; <xref ref-type="bibr" rid="bib13">De Moerlooze et al., 2000</xref>; <xref ref-type="bibr" rid="bib46">Sekine et al., 1999</xref>), while thymus was found to be the agenesis phenotype in the Foxa2-driven Fgfr2 knockout mice (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A</xref>).</p></sec><sec id="s2-6"><title>Generation of the entire lungs in <italic>Foxa2</italic>-driven <italic>Fgfr2</italic>-deficient mice via CBC</title><p>To examine whether donor cells complement the lung agenesis phenotype, we generated nGFP<sup>+</sup>iPSCs from Rosa<sup>nT-nG</sup> mice (hereafter, nGFP<sup>+</sup>iPSCs) via Sendai virus-mediated reprogramming (<xref ref-type="bibr" rid="bib26">Huang et al., 2014</xref>). nGFP<sup>+</sup>iPSCs were injected into mouse blastocysts (<xref ref-type="fig" rid="fig4">Figure 4A</xref>), and chimerism was analyzed at E17.5. Strikingly, donor nGFP<sup>+</sup>iPSCs generated whole lungs in <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO mice, but general chimerism in other organs were diverse (<xref ref-type="fig" rid="fig4">Figure 4B</xref>, <xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3A</xref>, and <xref ref-type="table" rid="table1">Table 1</xref>). Importantly, almost the entire lung epithelial, mesenchymal, and endothelial cell population at E17.5 was composed exclusively of nGFP<sup>+</sup>iPSCs (<xref ref-type="fig" rid="fig4">Figure 4C–E</xref> and <xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3B–D</xref>). In contrast, wild-type, Shh-driven heterozygous, or knockout mice showed about 6.48–92.3% chimerism in the mesenchymal and endothelial lineages of the lung (<xref ref-type="fig" rid="fig4">Figure 4E</xref>, <xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3C</xref>, and <xref ref-type="table" rid="table1">Table 1</xref>). We further compared the chimerism of each cell type in <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO mice and <italic>Shh<sup>Cre/+</sup>; Fgfr2</italic> cKO mice. Interestingly, Sma<sup>+</sup> lung airway mesenchyme (80.5 ± 12.0% vs 46.3 ± 16.6%, p = 0.0057), Pecam<sup>+</sup> capillary (87.5 ± 7.5% vs 62.7 ± 15.9%, p = 0.0134), and NG2<sup>+</sup> pericyte (80.6 ± 13.6% vs 57.5 ± 10.6%, p = 0.0171) showed higher chimerism in the complemented lungs of <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO mice (<xref ref-type="fig" rid="fig4">Figure 4F–H</xref>, <xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4</xref>) than that of <italic>Shh<sup>Cre/+</sup>; Fgfr2</italic> cKO mice. Given that the <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO mice showed shorter truncated trachea than <italic>Shh<sup>Cre/+</sup>; Fgfr2</italic> cKO mice (<xref ref-type="fig" rid="fig4s5">Figure 4—figure supplement 5A, B</xref>), the rescued trachea of <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO mice exhibited higher chimerism in epithelium than that of <italic>Shh<sup>Cre/+</sup>; Fgfr2</italic> cKO mice (95.4 ± 5.72% vs 70.82 ± 18.6%, p = 0 .0223) (<xref ref-type="fig" rid="fig4s5">Figure 4—figure supplement 5</xref>). <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO mice did not show the difference in CD45<sup>+</sup> cell chimerism (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3</xref>) compared with other genotyping because those cells originate from the yolk sac, liver, or spleen (<xref ref-type="bibr" rid="bib61">Yokomizo et al., 2022</xref>), the off-targeted organs. Interestingly, <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO mouse showed thymus agenesis phenotype (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>), but it was rescued by donor PSC injection into the blastocysts of <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO mice (<xref ref-type="fig" rid="fig4">Figure 4B</xref>, arrows). The chimerism in the Epcam<sup>+</sup> thymic epithelium showed higher in <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO mice than <italic>Shh<sup>Cre/+</sup>; Fgfr2</italic> cKO mice (92.4 ± 5.10% vs 28.7 ± 25.4%, p = 0 .0006) (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>). This result suggests that the PSC injection completely rescued both the thymus and lung aplasia phenotype, and lungs and thymus were co-generated in the <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO mice.</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>E17.5 chimerism of Foxa2 or Shh promoter-driven conditional blastocyst complementation.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="2" colspan="2"/><th align="center" valign="bottom" rowspan="2">Liver</th><th align="center" valign="bottom" rowspan="2">Hematopoietic cells</th><th align="center" valign="bottom" colspan="4">Lung</th></tr><tr><th align="center" valign="bottom">Whole</th><th align="center" valign="bottom">Epithelium</th><th align="center" valign="bottom">Mesenchyme</th><th align="center" valign="bottom">Endothelium</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="9"><italic>Foxa2-Cre</italic></td><td align="left" valign="middle" rowspan="5"><italic>Fgfr2</italic> cKO</td><td align="center" valign="bottom">56.2</td><td align="center" valign="bottom">71.3</td><td align="center" valign="bottom">91.8</td><td align="center" valign="bottom">99.8</td><td align="center" valign="bottom">92.3</td><td align="center" valign="bottom">73.1</td></tr><tr><td align="center" valign="bottom">54.5</td><td align="center" valign="bottom">64.9</td><td align="center" valign="bottom">90.6</td><td align="center" valign="bottom">99.7</td><td align="center" valign="bottom">89.8</td><td align="center" valign="bottom">91.7</td></tr><tr><td align="center" valign="bottom">48.3</td><td align="center" valign="bottom">62.9</td><td align="center" valign="bottom">90.3</td><td align="center" valign="bottom">99.6</td><td align="center" valign="bottom">86.7</td><td align="center" valign="bottom">76.7</td></tr><tr><td align="center" valign="bottom">39.4</td><td align="center" valign="bottom">57.8</td><td align="center" valign="bottom">87.7</td><td align="center" valign="bottom">99.8</td><td align="center" valign="bottom">86.2</td><td align="center" valign="bottom">73.9</td></tr><tr><td align="center" valign="bottom">14.4</td><td align="center" valign="bottom">21.1</td><td align="center" valign="bottom">58.9</td><td align="center" valign="bottom">99.5</td><td align="center" valign="bottom">57</td><td align="center" valign="bottom">38.6</td></tr><tr><td align="left" valign="middle" rowspan="4"><italic>Fgfr2</italic> hetero</td><td align="center" valign="bottom">60.2</td><td align="center" valign="bottom">68.7</td><td align="center" valign="bottom">65.9</td><td align="center" valign="bottom">51.6</td><td align="center" valign="bottom">75</td><td align="center" valign="bottom">68.1</td></tr><tr><td align="center" valign="bottom">55.8</td><td align="center" valign="bottom">70</td><td align="center" valign="bottom">88.8</td><td align="center" valign="bottom">76.1</td><td align="center" valign="bottom">89</td><td align="center" valign="bottom">88.5</td></tr><tr><td align="center" valign="bottom">24.8</td><td align="center" valign="bottom">32</td><td align="center" valign="bottom">42.1</td><td align="center" valign="bottom">44.6</td><td align="center" valign="bottom">38.4</td><td align="center" valign="bottom">41.1</td></tr><tr><td align="center" valign="bottom">9.7</td><td align="center" valign="bottom">12.6</td><td align="center" valign="bottom">21.2</td><td align="center" valign="bottom">50.7</td><td align="center" valign="bottom">19.3</td><td align="center" valign="bottom">13.4</td></tr><tr><td align="left" valign="middle" rowspan="22"><italic>Shh-Cre</italic></td><td align="left" valign="middle" rowspan="5"><italic>Fgfr2</italic> cKO</td><td align="center" valign="bottom">35.7</td><td align="center" valign="bottom">38.9</td><td align="center" valign="bottom">73.6</td><td align="center" valign="bottom">99.7</td><td align="center" valign="bottom">70.2</td><td align="center" valign="bottom">69.3</td></tr><tr><td align="center" valign="bottom">13</td><td align="center" valign="bottom">18.8</td><td align="center" valign="bottom">79.2</td><td align="center" valign="bottom">99.9</td><td align="center" valign="bottom">75.3</td><td align="center" valign="bottom">72.6</td></tr><tr><td align="center" valign="bottom">28.8</td><td align="center" valign="bottom">26.6</td><td align="center" valign="bottom">68.3</td><td align="center" valign="bottom">97.3</td><td align="center" valign="bottom">66</td><td align="center" valign="bottom">47.3</td></tr><tr><td align="center" valign="bottom">43.1</td><td align="center" valign="bottom">53.8</td><td align="center" valign="bottom">67.5</td><td align="center" valign="bottom">98</td><td align="center" valign="bottom">64.8</td><td align="center" valign="bottom">54.9</td></tr><tr><td align="center" valign="bottom">19.2</td><td align="center" valign="bottom">18.9</td><td align="center" valign="bottom">63.7</td><td align="center" valign="bottom">99.5</td><td align="center" valign="bottom">55.1</td><td align="center" valign="bottom">60.1</td></tr><tr><td align="left" valign="middle" rowspan="6"><italic>Fgfr2</italic><break/>hetero</td><td align="center" valign="bottom">57.4</td><td align="center" valign="bottom">12.7</td><td align="center" valign="bottom">33.6</td><td align="center" valign="bottom">38.3</td><td align="center" valign="bottom">33.4</td><td align="center" valign="bottom">22.1</td></tr><tr><td align="center" valign="bottom">44.4</td><td align="center" valign="bottom">44.8</td><td align="center" valign="bottom">84.3</td><td align="center" valign="bottom">96.8</td><td align="center" valign="bottom">81.8</td><td align="center" valign="bottom">71.2</td></tr><tr><td align="center" valign="bottom">13.8</td><td align="center" valign="bottom">52.8</td><td align="center" valign="bottom">83.1</td><td align="center" valign="bottom">98.3</td><td align="center" valign="bottom">79.1</td><td align="center" valign="bottom">82.9</td></tr><tr><td align="center" valign="bottom">16.2</td><td align="center" valign="bottom">6.8</td><td align="center" valign="bottom">26.1</td><td align="center" valign="bottom">20.9</td><td align="center" valign="bottom">21.6</td><td align="center" valign="bottom">9.58</td></tr><tr><td align="center" valign="bottom">41.2</td><td align="center" valign="bottom">48.6</td><td align="center" valign="bottom">70.3</td><td align="center" valign="bottom">83.6</td><td align="center" valign="bottom">66.3</td><td align="center" valign="bottom">52.6</td></tr><tr><td align="center" valign="bottom">40</td><td align="center" valign="bottom">41.5</td><td align="center" valign="bottom">76.8</td><td align="center" valign="bottom">71</td><td align="center" valign="bottom">76.5</td><td align="center" valign="bottom">66.6</td></tr><tr><td align="left" valign="middle" rowspan="11"><italic>Wild type</italic></td><td align="center" valign="bottom">79.1</td><td align="center" valign="bottom">100</td><td align="center" valign="bottom">89.5</td><td align="center" valign="bottom">90.4</td><td align="center" valign="bottom">83.2</td><td align="center" valign="bottom">80.7</td></tr><tr><td align="center" valign="bottom">60.1</td><td align="center" valign="bottom">53.8</td><td align="center" valign="bottom">68.5</td><td align="center" valign="bottom">77.6</td><td align="center" valign="bottom">65.3</td><td align="center" valign="bottom">66.4</td></tr><tr><td align="center" valign="bottom">22.3</td><td align="center" valign="bottom">17.8</td><td align="center" valign="bottom">56.7</td><td align="center" valign="bottom">17.8</td><td align="center" valign="bottom">60.8</td><td align="center" valign="bottom">65.6</td></tr><tr><td align="center" valign="bottom">20.1</td><td align="center" valign="bottom">15.4</td><td align="center" valign="bottom">53.1</td><td align="center" valign="bottom">54.5</td><td align="center" valign="bottom">52</td><td align="center" valign="bottom">50.8</td></tr><tr><td align="center" valign="bottom">2.64</td><td align="center" valign="bottom">4.08</td><td align="center" valign="bottom">8.82</td><td align="center" valign="bottom">13.8</td><td align="center" valign="bottom">6.48</td><td align="center" valign="bottom">8.69</td></tr><tr><td align="center" valign="bottom">24.3</td><td align="center" valign="bottom">19.1</td><td align="center" valign="bottom">54.9</td><td align="center" valign="bottom">65.1</td><td align="center" valign="bottom">51.1</td><td align="center" valign="bottom">30.4</td></tr><tr><td align="center" valign="bottom">23.9</td><td align="center" valign="bottom">18.6</td><td align="center" valign="bottom">54.2</td><td align="center" valign="bottom">44</td><td align="center" valign="bottom">55.3</td><td align="center" valign="bottom">30.9</td></tr><tr><td align="center" valign="bottom">49</td><td align="center" valign="bottom">51</td><td align="center" valign="bottom">59.6</td><td align="center" valign="bottom">76.7</td><td align="center" valign="bottom">56.5</td><td align="center" valign="bottom">31.3</td></tr><tr><td align="center" valign="bottom">19.8</td><td align="center" valign="bottom">15.6</td><td align="center" valign="bottom">45.7</td><td align="center" valign="bottom">47.4</td><td align="center" valign="bottom">30.4</td><td align="center" valign="bottom">70.4</td></tr><tr><td align="center" valign="bottom">2.9</td><td align="center" valign="bottom">2.19</td><td align="center" valign="bottom">43.3</td><td align="center" valign="bottom">39.4</td><td align="center" valign="bottom">37</td><td align="center" valign="bottom">32.5</td></tr><tr><td align="center" valign="bottom">77.1</td><td align="center" valign="bottom">69.7</td><td align="center" valign="bottom">91.3</td><td align="center" valign="bottom">96.2</td><td align="center" valign="bottom">89.7</td><td align="center" valign="bottom">91.3</td></tr></tbody></table></table-wrap><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Generation of the entire lungs in <italic>Foxa2</italic>-driven <italic>Fgfr2</italic>-deficient mice via conditional blastocyst complementation (CBC) at E17.5.</title><p>(<bold>A</bold>) Schema of CBC experiment: a2i/VPA/LIF-treated SSEA1<sup>high</sup> CD31<sup>high</sup> nGFP<sup>+</sup>iPSCs were sorted and injected into WT<italic>, Fgfr2</italic> hetero (heterozygous: <italic>Foxa2<sup>cre/+</sup>; Fgfr2<sup>flox/+</sup>; Rosa26<sup>tdTomato/+</sup></italic>), and <italic>Fgfr2</italic> cKO (homozygous: <italic>Foxa2<sup>cre/+</sup>; Fgfr2<sup>flox/flox</sup>; Rosa26<sup>tdTomato/+</sup></italic>) blastocysts. (<bold>B</bold>) Gross morphology, GFP (green: donor nGFP<sup>+</sup>iPSCs-derived signals) and tdTomato (host Foxa2-lineage-derived signals) fluorescence of freshly isolated lungs from E17.5 chimeric <italic>WT</italic> (left), <italic>Fgfr2</italic> hetero (left middle) and <italic>Fgfr2</italic> cKO (right middle) that were injected with nGFP<sup>+</sup>iPSCs. Control: littermate <italic>Fgfr2</italic> cKO mouse without nGFP<sup>+</sup>iPSCs injection (right). Arrows: rescued thymus formation. (<bold>C</bold>) Representative immunofluorescence (IF)-confocal imaging of E17.5 <italic>Fgfr2</italic> cKO or <italic>Fgfr2</italic> hetero lungs injected with nGFP<sup>+</sup>iPSCs. Dotted lines: enlarged images: <italic>Fgfr2</italic> hetero lungs holding host-derived cells. On the other hand, <italic>Fgfr2</italic> cKO lungs were entirely composed of donor-derived nGFP<sup>+</sup> cells. Scale bars left and right = 0.5 mm and 50 μm. Graphs: % GFP in (<bold>D</bold>) CD31<sup>−</sup>Epcam<sup>+</sup> lung epithelium and (<bold>E</bold>) CD31<sup>−</sup>Epcam<sup>−</sup> mesenchyme analyzed by flow cytometry. Each plot showed different biological animals. <italic>Foxa2<sup>Cre</sup>; Fgfr2</italic> cKO<italic>; Rosa<sup>tdTomato</sup></italic> (<italic>n</italic> = 5, independent biological replicates), <italic>Foxa2<sup>Cre</sup>; Fgfr2</italic> hetero<italic>; Rosa<sup>tdTomato</sup></italic> (<italic>n</italic> = 4), <italic>Shh<sup>Cre</sup>; Fgfr2</italic> cKO<italic>; Rosa<sup>tdTomato</sup></italic> (<italic>n</italic> = 5), <italic>Shh<sup>Cre/+</sup>; Fgfr2</italic> hetero<italic>; Rosa<sup>tdTomato</sup></italic> (<italic>n</italic> = 6), and <italic>WT</italic> (<italic>n</italic> = 11). Statistical analyses: unpaired Student’s <italic>t</italic>-test, significance at *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001. Error bars represent mean ± standard deviation (SD). Representative IF-confocal imaging of (<bold>F</bold>) <italic>Foxa2<sup>Cre</sup>; Fgfr2</italic> cKO<italic>; Rosa<sup>tdTomato</sup></italic> and (<bold>G</bold>) <italic>Shh<sup>Cre</sup>; Fgfr2</italic> cKO<italic>; Rosa<sup>tdTomato</sup></italic> injected with nGFP<sup>+</sup>iPSCs. (<bold>H</bold>) Morphometric analysis: % GFP in Nkx2-1+ epithelial cells (left) and Sma<sup>+</sup> airway smooth muscle cells (right) in <italic>Foxa2<sup>Cre</sup>; Fgfr2</italic> cKO<italic>; Rosa<sup>tdTomato</sup></italic> and <italic>Shh<sup>Cre</sup>; Fgfr2</italic> cKO<italic>; Rosa<sup>tdTomato</sup></italic>. Statistical analyses: unpaired Student’s <italic>t</italic>-test, significance if *p &lt; 0.05, **p &lt; 0.01, ns: non-significant. Error bars represent mean ± SD. Scale bars = 50 μm. (<bold>I</bold>) Representative IF-confocal imaging of E14.5 lung of <italic>Fgfr2</italic> cKO injected with nGFP<sup>+</sup>iPSCs. GFP and tdTomato indicate donor and host-derived cells, respectively. Scale bar = 20 μm. (<bold>J</bold>) Split images of (I) visualizing GFP<sup>+</sup> donor cells and tdTomato<sup>+</sup> host cells, co-stained with Ki67. Scale bar = 20 μm. (<bold>K</bold>) Graphs: % Ki67 labeling in mesenchymal cells of E14.5 <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO chimeric lungs. Statistical analyses: paired Student’s <italic>t</italic>-test, significance if *p &lt; 0.05, ns: non-significant. Error bars represent mean ± SD.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Morphometric analysis: % GFP in Nkx2-1<sup>+</sup> epithelial cells and Sma<sup>+</sup> airway smooth muscle cells in <italic>Foxa2<sup>Cre</sup>; Fgfr2</italic> cKO<italic>; Rosa<sup>tdTomato</sup></italic> and <italic>Shh<sup>Cre</sup>; Fgfr2</italic> cKO<italic>; Rosa<sup>tdTomato</sup></italic>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-86105-fig4-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title>Morphometric analysis: % Ki67 labeling in mesenchymal cells of E14.5 <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO chimeric lungs.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-86105-fig4-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86105-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Lung agenesis phenotype in the <italic>Foxa2<sup>Cre/+</sup>Fgfr2</italic> cKO mice.</title><p>(<bold>A</bold>) Representative gross morphology of E14.5 <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> hetero and <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO. There were no differences in the appearance of the embryos between <italic>Fgfr2</italic> hetero and <italic>Fgfr2</italic> cKO. Limb (arrows) and placenta (pl) are present in all genotypes. Conversely, the <italic>Fgfr2</italic> cKO embryo showed lung agenesis phenotype (bottom, asterisk) (<italic>n</italic> = 6 per each group). (<bold>B</bold>) Representative immunofluorescence (IF)-confocal imaging of E10.5 <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> hetero and <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO: <italic>Fgfr2</italic> cKO did not form Sox2<sup>+</sup>NKX2-1<sup>+</sup> proximal airway bifurcation. Scale bar = 20 μm. Lu: lung, Eso: esophagus, Tr: trachea. (<bold>C</bold>) HE stains and IF imaging of <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO<italic>; Rosa26<sup>tdTomato/+</sup></italic> at E16.5. tdTomato (red) signal indicate Foxa2 lineage. The internal organs such as the intestine, pancreas, kidney, tooth buds, and hair follicles were normally formed in <italic>Fgfr2</italic> cKO. Scale bar = 200 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86105-fig4-figsupp1-v2.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>The complemented embryos of <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO <italic>and Shh<sup>Cre/+</sup>; Fgfr2</italic> cKO + nGFP<sup>+</sup>iPSCs showed different chimerism in thymus epithelial cells.</title><p>(<bold>A</bold>) Representative image of <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO<italic>; Rosa26<sup>tdTomato/+</sup></italic>, <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> hetero<italic>; Rosa26<sup>tdTomato/+</sup></italic>, and <italic>Shh<sup>Cre/+</sup>; Fgfr2</italic> cKO<italic>; Rosa26<sup>tdTomato/+</sup>. Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO<italic>; Rosa26<sup>tdTomato/+</sup></italic> showed thymus and lung agenesis, while <italic>Shh<sup>Cre/+</sup>; Fgfr2</italic> cKO<italic>; Rosa26<sup>tdTomato/+</sup></italic> showed only lung agenesis. Lu: lung, Ht: heart, Tr: trachea, Th: thymus. (<bold>B</bold>) Representative immunofluorescence (IF) imaging of E17.5 thymus of <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO<italic>; Rosa26<sup>tdTomato/+</sup></italic> and <italic>Shh<sup>Cre/+</sup>; Fgfr2</italic> cKO<italic>; Rosa26<sup>tdTomato/+</sup></italic> injected with nGFP<sup>+</sup>iPSCs. GFP indicates donor cells. Dotted line: Epcam<sup>+</sup> thymic epithelial cells. Scale bar = 20 μm. (<bold>C</bold>) Graphs: % chimerism of thymus epithelium and mesenchyme. Each plot showed different embryos. <italic>Foxa2<sup>Cre</sup>; Fgfr2</italic> cKO<italic>; Rosa<sup>tdTomato</sup></italic> (<italic>n</italic> = 5, independent biological replicates), <italic>Foxa2<sup>Cre</sup>; Fgfr2</italic> hetero<italic>; Rosa<sup>tdTomato</sup></italic> (<italic>n</italic> = 3), <italic>Shh<sup>Cre</sup>; Fgfr2</italic> cKO<italic>; Rosa<sup>tdTomato</sup></italic> (<italic>n</italic> = 5). Statistical analysis: one-way analysis of variance (ANOVA) with the Tukey post hoc test; statistically significant at *p &lt; 0.05, ***p &lt; 0.001, ns: non-significant. Each plot showed different embryos. Error bars represent mean ± standard deviation (SD).</p><p><supplementary-material id="fig4s2sdata1"><label>Figure 4—figure supplement 2—source data 1.</label><caption><title>Morphometric immunofluorescence (IF) analysis of chimeric thymus: % chimerism of thymus epithelium and mesenchyme.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-86105-fig4-figsupp2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86105-fig4-figsupp2-v2.tif"/></fig><fig id="fig4s3" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 3.</label><caption><title>The complemented embryos of <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO + nGFP<sup>+</sup>iPSCs showed normal gross morphology and various chimerism.</title><p>(<bold>A</bold>) Representative gross morphology of chimeric embryos of <italic>WT</italic> + nGFP<sup>+</sup>iPSCs, <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> hetero<italic>; Rosa26<sup>tdTomato/+</sup></italic> + nGFP<sup>+</sup>iPSCs<italic>, Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO<italic>; Rosa26<sup>tdTomato/+</sup></italic> + nGFP<sup>+</sup>iPSCs. The color indicated various GFP<sup>+</sup> chimerism on the skin of those embryos and the residual host Foxa2-lineage tdTomato signals. (<bold>B</bold>) Representative immunofluorescence (IF)-confocal imaging of E17.5 lungs of chimeric <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO<italic>; Rosa26<sup>tdTomato/+</sup></italic> + nGFP<sup>+</sup>iPSCs. The E17.5 rescued lungs expressed differentiated cell markers such as Pdpn (alveolar type1 cells), Sftpc (type 2 cells), Scgb1a1 (club cells), Foxj1 (multiciliated cells), Cgrp (neuroendocrine cells), Sma (smooth muscle cells), and VE-cadherin (endothelial cells). Scale bar = 20 μm. Graphs: % GFP in (<bold>C</bold>) CD31<sup>+</sup>Epcam<sup>−</sup> lung endothelium and (<bold>D</bold>) CD45<sup>+</sup> hematopoietic cells analyzed by flow cytometry. Each plot showed different biological animals. <italic>Foxa2<sup>Cre</sup>; Fgfr2</italic> cKO<italic>; Rosa<sup>tdTomato</sup></italic> (<italic>n</italic> = 5, independent biological replicates), <italic>Foxa2<sup>Cre</sup>; Fgfr2</italic> hetero<italic>; Rosa<sup>tdTomato</sup></italic> (n = 4), <italic>Shh<sup>Cre</sup>; Fgfr2</italic> cKO<italic>; Rosa<sup>tdTomato</sup></italic> (<italic>n</italic> = 5), <italic>Shh<sup>Cre/+</sup>; Fgfr2</italic> hetero<italic>; Rosa<sup>tdTomato</sup></italic> (<italic>n</italic> = 6), and <italic>WT</italic> (<italic>n</italic> = 11). Error bars represent mean ± standard deviation (SD). Statistical analyses: unpaired Student’s <italic>t</italic>-test, significance at *p &lt; 0.05, ns: non-significant. (<bold>E</bold>) Graphs: % of donor cell chimerism at E14.5: % of GFP in CD31<sup>−</sup>Epcam<sup>+</sup> lung epithelium fraction, CD31<sup>−</sup>Epcam<sup>−</sup> mesenchyme, and CD31<sup>+</sup>Epcam<sup>−</sup> endothelium analyzed by flow cytometry. Each plot: a different biological animal (see <xref ref-type="table" rid="table2">Table 2</xref>). <italic>Foxa2<sup>Cre</sup>; Fgfr2</italic> cKO<italic>; Rosa<sup>tdTomato</sup></italic> (<italic>n</italic> = 3, independent biological replicates), <italic>Foxa2<sup>Cre</sup>; Fgfr2</italic> hetero<italic>; Rosa<sup>tdTomato</sup></italic> (<italic>n</italic> = 5), and <italic>WT</italic> (<italic>n</italic> = 5) at E14.5. Error bars represent mean ± SD. Statistical analyses: unpaired Student’s <italic>t</italic>-test, significance at *p &lt; 0.05, ns: non-significant. (<bold>F</bold>) Representative IF-confocal imaging of E14.5 Shh-lineage-tracing mouse lungs (<italic>Shh<sup>Cre/+</sup>; Rosa<sup>tdTomato/+</sup></italic>). Shh-lineage labeled the entire lung epithelium but rarely mesenchyme, distinct from Foxa2 lineage mice (see <xref ref-type="fig" rid="fig2">Figure 2F</xref>). Scale bar = 100 μm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86105-fig4-figsupp3-v2.tif"/></fig><fig id="fig4s4" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 4.</label><caption><title>The complemented embryos of <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO <italic>and Shh<sup>Cre/+</sup>; Fgfr2</italic> cKO + nGFP<sup>+</sup>iPSCs showed different chimerism in each lung cell type.</title><p>Representative immunofluorescence (IF)-confocal imaging of E17.5 lung of <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO and <italic>Shh<sup>Cre/+</sup>; Fgfr2</italic> cKO injected with nGFP<sup>+</sup>iPSCs. GFP indicates donor cells. Graphs: % chimerism of GFP+ donor cells with E17.5 lung mesenchyme markers such as SMA<sup>+</sup> PECAM<sup>+</sup> artery, SMA<sup>-</sup> PECAM<sup>+</sup> veins, PECAM<sup>+</sup> capillaries, NG2+ pericytes, and WT1+ mesothelium. Each plot showed different embryos. <italic>Foxa2<sup>Cre</sup>; Fgfr2</italic> cKO<italic>; Rosa<sup>tdTomato</sup></italic> (<italic>n</italic> = 5, independent biological replicates) and <italic>Shh<sup>Cre</sup>; Fgfr2</italic> cKO<italic>; Rosa<sup>tdTomato</sup></italic> (<italic>n</italic> = 5). <italic>N</italic> = 5 biological replicates. Error bars represent mean ± standard deviation (SD). Statistical analyses: unpaired Student’s <italic>t</italic>-test, significance at *p &lt; 0.05, ns: non-significant. Scale bar = 20 μm.</p><p><supplementary-material id="fig4s4sdata1"><label>Figure 4—figure supplement 4—source data 1.</label><caption><title>Morphometric analysis of E17.5 chimeric lungs in each lung mesenchyme marker.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-86105-fig4-figsupp4-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86105-fig4-figsupp4-v2.tif"/></fig><fig id="fig4s5" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 5.</label><caption><title>The complemented embryos of <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO <italic>and Shh<sup>Cre/+</sup>; Fgfr2</italic> cKO + nGFP<sup>+</sup>iPSCs showed different chimerism in tracheal epithelial cells.</title><p>(<bold>A, B</bold>) Representative image of <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO<italic>; Rosa26<sup>tdTomato/+</sup></italic> and <italic>Shh<sup>Cre/+</sup>; Fgfr2</italic> cKO; <italic>Rosa26<sup>tdTomato/+</sup></italic>trachea. Asterisks indicate the trachea end. Foxa2 trachea ends in the middle of the thoracic cavity, while Shh ends after bifurcation. (<bold>C, D</bold>) Representative immunofluorescence (IF)-confocal imaging of E17.5 trachea of (<bold>C</bold>) <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO<italic>; Rosa<sup>tdTomato</sup></italic> and (<bold>D</bold>) <italic>Shh<sup>Cre/+</sup>; Fgfr2</italic> cKO<italic>; Rosa<sup>tdTomato</sup></italic> injected with nGFP<sup>+</sup>iPSCs. GFP and tdTomato indicate donor cells and host lineage cells, respectively. Dotted lines: enlarged images. (<bold>E</bold>) Graphs: % chimerism of tracheal epithelium and mesenchyme. each plot showed different embryos. <italic>Foxa2<sup>Cre</sup>; Fgfr2</italic> cKO<italic>; Rosa<sup>tdTomato</sup></italic> (<italic>n</italic> = 5, independent biological replicates), <italic>Foxa2<sup>Cre</sup>; Fgfr2</italic> hetero<italic>; Rosa<sup>tdTomato</sup></italic> (<italic>n</italic> = 3), <italic>Shh<sup>Cre</sup>; Fgfr2</italic> cKO<italic>; Rosa<sup>tdTomato</sup></italic> (<italic>n</italic> = <italic>5</italic>). Statistical analysis: one-way analysis of variance (ANOVA) with the Tukey post hoc test; statistically significant at *p &lt; 0.05, **p &lt; 0.01, ns: non-significant. Error bars represent mean ± standard deviation (SD).</p><p><supplementary-material id="fig4s5sdata1"><label>Figure 4—figure supplement 5—source data 1.</label><caption><title>Morphometric immunofluorescence (IF) analysis of the chimeric trachea: % chimerism of tracheal epithelium and mesenchyme.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-86105-fig4-figsupp5-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86105-fig4-figsupp5-v2.tif"/></fig></fig-group></sec><sec id="s2-7"><title>Fgfr2 knockout in lung mesenchyme suppressed their proliferation and showed higher chimerism of the entire lung by CBC</title><p>Previous reports described that Fgfr2 is critical for lung epithelial cell development but also important for lung mesenchyme proliferation (<xref ref-type="bibr" rid="bib60">Yin et al., 2008</xref>). Although tdTomato<sup>+</sup> Fgfr2 knockout mesenchymal cells remained in early lung development at E14.5 (<xref ref-type="fig" rid="fig4">Figure 4I</xref>), the percentage of Ki67<sup>+</sup> proliferating cells was significantly higher in GFP<sup>+</sup> donor cells compared to tdTomato<sup>+</sup> host cells (<xref ref-type="fig" rid="fig4">Figure 4J, K</xref>). These results suggest that generating Fgfr2-deficient niche in the host Foxa2-lineage-derived lung mesenchyme is efficient for donor iPSCs recruitment in the defective Foxa2 lineage mesenchyme niches during development.</p></sec><sec id="s2-8"><title>Generation of functional lungs in <italic>Foxa2</italic>-driven <italic>Fgfr2</italic>-deficient mice via CBC</title><p>Although we observed nearly the whole lung generation in the <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO during lung development, it was unclear whether the Foxa2-lineage-based CBC approach was efficient enough for obtaining fully functional lungs and the rescued mice would survive until adulthood. We injected GFP-expressing mouse embryonic stem cells (PSC<sup>CAG-GFP</sup>) into mouse blastocysts and analyzed the chimeric mice postnatal days to address this issue. We found that <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO, PSC<sup>CAG-GFP</sup> rescued mice survived at 4 weeks postnatal days without any difference in their gross appearance and behavior from the littermate control; <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> hetero, PSC<sup>CAG-GFP</sup> mice (<xref ref-type="fig" rid="fig5">Figure 5A</xref>, asterisks). They showed no significant difference in their respiratory functions of <italic>f</italic> (frequency) (232.9 ± 18.5 vs 236.2 ± 25.7%, p = 0.790), TV (tidal volume) (0.253 ± 0.06 vs 0.233 ± 0.06, p = 0.514), Raw (airway resistance) (4.340 ± 1.65 vs 5.393 ± 3.80, p = 0.556), and EF50 (expiratory flow at the point 50% of TV is expired) (2.484 ±0 .513 vs 2.376 ±0 .860, p = 0.793) (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). Macroscopic analysis showed strong GFP signals but little host-derived tdTomato signals in the lungs of <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO, PSC<sup>CAG-GFP</sup> rescued mice compared to littermate controls (<xref ref-type="fig" rid="fig5">Figure 5C, D</xref>), suggesting efficient donor complementation in both epithelial and mesenchymal lung progenitors. FCM analyses confirmed a significantly lower proportion of the residual tdTomato<sup>+</sup> host-derived cells in the epithelium (0.29% ± 0.40 vs 45.9% ± 24.1, p = 0.0004), mesenchyme (1.80% ± 1.94 vs 28.1% ± 11.5, p &lt; 0.0001), and endothelium (3.86% ± 4.89 vs 44.6% ± 16.5, p &lt; 0.0001) of the complemented adult lungs compared to the littermate control (<xref ref-type="fig" rid="fig5">Figure 5E, F</xref>). IF of lungs from <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO, PSC<sup>CAG-GFP</sup> rescued animals confirmed extensive GFP overlap with markers of the airway and alveolar epithelial cell types and mesenchyme (<xref ref-type="fig" rid="fig5">Figure 5G</xref>). We also confirmed that PSC<sup>CAG-GFP</sup> injection into <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO blastocysts simultaneously rescued the thymus agenesis phenotype (<xref ref-type="fig" rid="fig5">Figure 5C, H</xref>, arrows).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Generation of fully functional adult lungs in <italic>Foxa2</italic>-driven <italic>Fgfr2</italic>-deficient mice via conditional blastocyst complementation (CBC).</title><p>(<bold>A</bold>) Adult mice of <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO<italic>; Rosa<sup>tdTomato</sup></italic> (asterisks) or <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> hetero<italic>; Rosa<sup>tdTomato</sup></italic> injected with PSC<sup>CAG-GFP</sup>. (<bold>B</bold>) Graphs: Respiratory function analysis of <italic>f</italic> (frequency), TV (tidal volume), Raw (airway resistance), and EF50 (expiratory flow at the point 50% of TV is expired) of <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO<italic>; Rosa<sup>tdTomato</sup></italic> (<italic>n</italic> = 5, independent biological replicates), <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> hetero<italic>; Rosa<sup>tdTomato</sup></italic> (<italic>n</italic> = 19). Statistical analyses: unpaired Student’s <italic>t</italic>-test, significance at ns: non-significant. (<bold>C</bold>) Gross morphology of 4 weeks rescued lung and thymus from <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO<italic>; Rosa<sup>tdTomato</sup> (Fgfr2</italic> cKO) or <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> hetero<italic>; Rosa<sup>tdTomato</sup></italic> (<italic>Fgfr2</italic> hetero) injected with PSC<sup>CAG-GFP</sup>. Scale bar = 5 mm. (<bold>D</bold>) Fluorescent signals of 4 weeks chimeric lungs. GFP (green: donor PSC<sup>CAG-GFP</sup>-derived signals) and tdTomato (red: host Foxa2-lineage-derived signals) fluorescence of freshly isolated lungs after removing thymus. Scale bar = 5 mm. (<bold>E</bold>) Representative immunofluorescence (IF) tiled-scan confocal-IF imaging of 4 weeks <italic>Fgfr2</italic> cKO or <italic>Fgfr2</italic> hetero lungs injected with PSC<sup>CAG-GFP</sup>. <italic>Fgfr2</italic> cKO lungs showed less host origin tdTomato<sup>+</sup> cells compared to <italic>Fgfr2</italic> hetero. Scale bar = 3 mm. (<bold>F</bold>) Flow cytometry (FCM) analysis: Graphs: Remaining tdTomato<sup>+</sup> cell population of each cell type in 4 weeks <italic>Fgfr2</italic> cKO or <italic>Fgfr2</italic> hetero lungs injected with PSC<sup>CAG-GFP</sup>. Statistical analyses: unpaired Student’s <italic>t</italic>-test, significance if ***p &lt; 0.001 and ****p &lt; 0.0001. (<bold>G</bold>) Representative IF-confocal imaging of 4 weeks chimeric lungs from <italic>Fgfr2</italic> cKO or <italic>Fgfr2</italic> hetero injected with PSC<sup>CAG-GFP</sup> expressed differentiated cell markers such as Pdpn (alveolar type1 cells), Sftpc (type 2 cells), Scgb1a1 (club cells), Sma (smooth muscle cells), and VE-cadherin (endothelial cells). Scale bar = 20 μm. (<bold>H</bold>) Fluorescent signals of 4 weeks chimeric thymus. Arrows in C and H: rescued thymus formation, Scale bar = 1 mm.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Respiratory function analysis of <italic>f</italic> (frequency), TV (tidal volume), Raw (airway resistance), and EF50 (expiratory flow at the point 50% of TV is expired) of <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO<italic>; Rosa<sup>tdTomato</sup></italic>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-86105-fig5-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig5sdata2"><label>Figure 5—source data 2.</label><caption><title>Flow cytometry (FCM) analysis: remaining tdTomato<sup>+</sup> cell population of each cell type in 4 weeks <italic>Fgfr2</italic> cKO or <italic>Fgfr2</italic> hetero lungs injected with PSC<sup>CAG-GFP</sup>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-86105-fig5-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86105-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Summary of the results and proposed models.</title><p>(<bold>A</bold>) Pluripotent stem cell (PSC) differentiation will be initiated by the Mixl1<sup>+</sup> induction and the subsequent temporal expression of an early mesendoderm (ME) marker, Pdgfrα. After that, the late mesendoderm marker marked by Foxa2 will turn on. Pdgfrα and Foxa2 lineage partially overlap at the distal component of primitive streak stage during gastrulation. Pdgfrα<sup>+</sup> early ME lineage gives rise to the partial lung epithelial cells, most likely by the overlapping Foxa2<sup>+</sup> lineage and entire lung mesenchyme through lateral plate mesoderm (LPM) induction and cardiopulmonary lineage (CPP). On the other hand, the Foxa2 lineage gives rise to the whole lung epithelium and about 20% of CPP in early lung development at E12.5–E14.5. Strikingly, the whole lungs, including lung epithelium, mesenchyme, and endothelial cells, were produced solely by donor induced pluripotent stem cells (iPSCs) via complementing the Foxa2-lineage’s mitotic defective lung niches. (<bold>B</bold>) Top left panel: Schematic diagram of mesendoderm lineage trajectory for lung formation based on the single-cell RNA-seq (scRNA-seq) deposited database (<xref ref-type="bibr" rid="bib42">Pijuan-Sala et al., 2019</xref>). During gastrulation, a bipotent mesendoderm (Mes: rounded blue area) appears in the transition from primitive streak (PS) and NM, labeled by <italic>Mixl1</italic>, <italic>T</italic>, <italic>Gsc</italic>, and <italic>Eomes</italic>. NM forms LPM. Mesendoderm also gives rise to anteriolar PS (APS) and, subsequently, definitive endoderm (DE). Top right panel: Clustering of scRNA-seq provided in the deposited database (<xref ref-type="bibr" rid="bib42">Pijuan-Sala et al., 2019</xref>). Bottom left panel: Time point of scRNA-seq provided in the deposited database (<xref ref-type="bibr" rid="bib42">Pijuan-Sala et al., 2019</xref>). Bottom: <italic>Foxa2</italic> is expressed in the PS (black arrow) and the part of NM (red arrow). In contrast, <italic>Shh</italic> appeared in DE but not in PS, NM, or APS. A few cells showed <italic>Pdgfrα</italic> in PS (black arrow) but most expressed <italic>Pdgfra</italic> in NM (red arrow) and LPM.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86105-fig5-figsupp1-v2.tif"/></fig></fig-group><p>These results indicate that <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO provides defective niches in both lung epithelium and mesenchyme and thymic epithelium to be complemented by donor PSCs, enabling the entire lungs and thymus co-generation.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>The presence of committed organ precursors capable of contributing to multi-embryonic layers after pluripotent epiblast formation has been assumed, but the identity and origin of the lung precursors needed to be better defined. Although the Foxa2 lineage could not give rise to the entire lung cells, we have identified a Foxa2 lineage that provides a significant steppingstone for facilitating functional whole lung generation. Since donor cells formed about 50–80% chimerism in the complemented lung mesenchyme niches at E14.5 (<xref ref-type="table" rid="table2">Table 2</xref>) and endogenous Foxa2 lineage forms only 20–30% in the lung mesenchyme at E14.5, Fgfr2 defects at the Foxa2 lineage in early lung development are important but not sufficient for the complete lung mesenchyme niche complementation. Losing Fgfr2 expression in Foxa2 lineage cells resulted in lower proliferative ability than donor cells during chimeric lung mesenchyme development (<xref ref-type="fig" rid="fig4">Figure 4I–K</xref>), allowing progressive lung mesenchyme complementation in lung development and postnatal days, leading to promoting efficient whole lung generation.</p><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>E14.5 chimerism of Foxa2 promoter-driven conditional blastocyst complementation.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="2" colspan="2"/><th align="center" valign="bottom" rowspan="2">Liver</th><th align="center" valign="bottom" colspan="4">Lung</th></tr><tr><th align="center" valign="bottom">Whole</th><th align="center" valign="bottom">Epithelium</th><th align="center" valign="bottom">Mesenchyme</th><th align="center" valign="bottom">Endothelium</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="13"><italic>Foxa2-Cre</italic></td><td align="left" valign="middle" rowspan="3"><italic>Fgfr2</italic> cKO</td><td align="center" valign="bottom">59.9</td><td align="center" valign="bottom">81.9</td><td align="center" valign="bottom">99.4</td><td align="center" valign="bottom">81.4</td><td align="center" valign="bottom">86.2</td></tr><tr><td align="center" valign="bottom">51</td><td align="center" valign="bottom">75.4</td><td align="center" valign="bottom">99.4</td><td align="center" valign="bottom">75.4</td><td align="center" valign="bottom">56.8</td></tr><tr><td align="center" valign="bottom">25.3</td><td align="center" valign="bottom">56.5</td><td align="center" valign="bottom">97.4</td><td align="center" valign="bottom">54.1</td><td align="center" valign="bottom">63.2</td></tr><tr><td align="left" valign="middle" rowspan="5"><italic>Fgfr2</italic> hetero</td><td align="center" valign="bottom">37.1</td><td align="center" valign="bottom">54.4</td><td align="center" valign="bottom">56.9</td><td align="center" valign="bottom">54</td><td align="center" valign="bottom">58.9</td></tr><tr><td align="center" valign="bottom">29.8</td><td align="center" valign="bottom">48.6</td><td align="center" valign="bottom">83.3</td><td align="center" valign="bottom">47.7</td><td align="center" valign="bottom">47.3</td></tr><tr><td align="center" valign="bottom">18.7</td><td align="center" valign="bottom">43.4</td><td align="center" valign="bottom">18</td><td align="center" valign="bottom">45</td><td align="center" valign="bottom">31</td></tr><tr><td align="center" valign="bottom">0.54</td><td align="center" valign="bottom">0.24</td><td align="center" valign="bottom">0.91</td><td align="center" valign="bottom">0.1</td><td align="center" valign="bottom">2.11</td></tr><tr><td align="center" valign="bottom">0.4</td><td align="center" valign="bottom">0.17</td><td align="center" valign="bottom">1.02</td><td align="center" valign="bottom">0.058</td><td align="center" valign="bottom">1.23</td></tr><tr><td align="left" valign="middle" rowspan="5"><italic>Wild type</italic></td><td align="center" valign="bottom">39</td><td align="center" valign="bottom">68.7</td><td align="center" valign="bottom">56.2</td><td align="center" valign="bottom">69.2</td><td align="center" valign="bottom">67.5</td></tr><tr><td align="center" valign="bottom">29.4</td><td align="center" valign="bottom">81.1</td><td align="center" valign="bottom">62.7</td><td align="center" valign="bottom">81.8</td><td align="center" valign="bottom">80.8</td></tr><tr><td align="center" valign="bottom">28.6</td><td align="center" valign="bottom">73.9</td><td align="center" valign="bottom">39.6</td><td align="center" valign="bottom">75.6</td><td align="center" valign="bottom">76.4</td></tr><tr><td align="center" valign="bottom">13.8</td><td align="center" valign="bottom">29.5</td><td align="center" valign="bottom">5.57</td><td align="center" valign="bottom">30.4</td><td align="center" valign="bottom">29.6</td></tr><tr><td align="center" valign="bottom">0</td><td align="center" valign="bottom">2.22</td><td align="center" valign="bottom">5.52</td><td align="center" valign="bottom">1.5</td><td align="center" valign="bottom">16</td></tr></tbody></table></table-wrap><p>Lung epithelial cell precursors were well known to be Shh<sup>+</sup> DE in the lung development field (<xref ref-type="bibr" rid="bib6">Cardoso and Kotton, 2008</xref>; <xref ref-type="bibr" rid="bib10">Christodoulou et al., 2011</xref>; <xref ref-type="bibr" rid="bib22">Harris et al., 2006</xref>; <xref ref-type="bibr" rid="bib27">Kadzik and Morrisey, 2012</xref>; <xref ref-type="bibr" rid="bib49">Tian et al., 2011</xref>; <xref ref-type="bibr" rid="bib55">Weaver et al., 1999</xref>; <xref ref-type="bibr" rid="bib57">Xing et al., 2008</xref>), and indeed, the Shh-lineage traces putative DE-derived epithelial lineage but little lung mesenchyme (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3</xref>). Targeting the endodermal lung lineage driven by Shh was sufficient for lung epithelial complementation but insufficient to generate whole lungs, and host-derived cells remained substantially in the mesodermal lung component (<xref ref-type="bibr" rid="bib36">Mori et al., 2019</xref>).</p><p>In contrast to lung epithelial precursors, the orderly commitment and the origin of the entire pulmonary mesenchyme needed to be better defined. We showed that gastrulating Pdgfrα lineage is the origin of the whole lung mesoderm, including endothelium (<xref ref-type="fig" rid="fig1">Figure 1A, B</xref>). Furthermore, Foxa2 or Pdgfrα lineage labels a population primarily comprised of the earliest specified precursors in the distal compartment of mesendoderm, similar to human iPSC cell-derived directed differentiation protocol. Our findings, summarized in <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>, pinpoint the lineage hierarchy of specified lung precursors in gastrulating mesendoderm, further supported by the scRNA-seq analysis in early embryonic development (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>; <xref ref-type="bibr" rid="bib42">Pijuan-Sala et al., 2019</xref>).</p><p>As previously indicated that nascent mesoderm differentiation into a CPP fate (<xref ref-type="bibr" rid="bib3">Bardot et al., 2017</xref>; <xref ref-type="bibr" rid="bib14">Devine et al., 2014</xref>; <xref ref-type="bibr" rid="bib37">Ng et al., 2022</xref>; <xref ref-type="bibr" rid="bib39">Peng et al., 2013</xref>), we clarified the orderly mesendoderm progression of gene expression, Mixl1, Pdgfrα, and Foxa2, and lung progenitor-related markers that parallels the commitment of Foxa2<sup>+</sup> Pdgfrα<sup>+</sup> mesendoderm to an LPM and DE fate in the lung-directed differentiation protocol using human iPSC (<xref ref-type="fig" rid="fig3">Figure 3</xref>), not clarified in the previous pioneering works (<xref ref-type="bibr" rid="bib8">Chen et al., 2017</xref>; <xref ref-type="bibr" rid="bib24">Hawkins et al., 2017</xref>; <xref ref-type="bibr" rid="bib26">Huang et al., 2014</xref>). We uncovered that PDGFRα<sup>+</sup> mesendoderm primes the cell fate of Foxa2<sup>+</sup> DE after the MIXL1<sup>+</sup> mesendoderm specification in the directed differentiation. How the lung progenitors acquire the lung epithelial cell fate of NKX2-1 with the distal lung tip marker, SOX9, and TBX4<sup>+</sup> mesenchyme marker is also fundamental for understanding human lung development.</p><p>Our lineage tracing analysis also highlighted the unanticipated Foxa2 lineage program, the progressive increase of lineage labeling by spontaneous expression of <italic>Foxa2 mRNA</italic> that occupies more than half of the lung mesenchyme during lung development. Foxa2 lineage<sup>+</sup> lung mesenchyme is a part of Pdgfrα lineage<sup>+</sup> cells, potentially providing a unique competitive developmental niche during lung development. Further analyses using Foxa2CreERT2-lineage-tracing mice are required to clarify it. Intriguingly, the Foxa2 lineage<sup>+</sup> mesenchyme did not show any discrete fates that would predict anatomical localization—depleting Fgfr2 in the Foxa2 lineage results in the loss of the Fgfr2 mitogen-mediated function of Foxa2 lineage<sup>+</sup> lung mesenchyme, which leads to the loss of proliferative ability in most host lung mesenchyme. The Foxa2-lineage labeling in lung mesenchyme is around 20% at E14.5 (<xref ref-type="fig" rid="fig2">Figure 2D, E</xref>). Moreover, the donor cell complementation in lung mesenchyme at E14.5 still holds host-derived lung mesenchyme but decreases at E17.5 and adulthood (<xref ref-type="fig" rid="fig4">Figures 4I, C</xref>, <xref ref-type="fig" rid="fig5">5E, F</xref>). These results indicate that the defective Foxa2 lineage is critically essential for efficient lung complementation.</p><p>We also found that the combination of Fgfr2 depletion in Foxa2 lineage preserved other major organs, such as kidney, glandular stomach, hair follicles, tooth bud, and limbs, distinct from the agenesis or dysgenesis phenotype caused by the systemic Fgfr2 depletion (<xref ref-type="bibr" rid="bib1">Arman et al., 1999</xref>; <xref ref-type="bibr" rid="bib12">De Langhe et al., 2006</xref>; <xref ref-type="bibr" rid="bib13">De Moerlooze et al., 2000</xref>; <xref ref-type="bibr" rid="bib46">Sekine et al., 1999</xref>). This is because the timing and the requirement of Fgfr2 are different from the lineage in each organ (<xref ref-type="bibr" rid="bib4">Bates, 2011</xref>; <xref ref-type="bibr" rid="bib44">Revest et al., 2001</xref>). We accidentally found a thymus agenesis phenotype in the <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO mice but not in <italic>Shh<sup>Cre/+</sup>; Fgfr2</italic> cKO mice and its complementation. The thymus is raised in the third pharyngeal pouch with the requirement of the Forkhead Box N1 (Foxn1) transcription factor in epithelial cells (<xref ref-type="bibr" rid="bib9">Chhatta et al., 2021</xref>), while the redundant role of Foxa2 and Foxa1 in T cell maturation was reported (<xref ref-type="bibr" rid="bib43">Ramachandran et al., 2022</xref>). The previous report generated thymus using BC by the Foxn1 depletion in host animals, followed by the PSC injections (<xref ref-type="bibr" rid="bib59">Yamazaki et al., 2022</xref>). Our reports showed novel evidence of the requirement of Fgfr2 signaling for thymus formation, specifically in the Foxa2 lineage, associated with the previous statements regarding the critical role of Fgfr2 in thymus formation and thymic epithelial cell differentiation (<xref ref-type="bibr" rid="bib15">Dooley et al., 2007</xref>; <xref ref-type="bibr" rid="bib44">Revest et al., 2001</xref>). This study showed evidence that thymus formation is essentially formed in the Foxa2 lineage but not Shh, supported by the previous report that the dynamic Shh expression regulates larynx-esophageal separation and esophageal constriction on the fourth pharyngeal pouches above the lungs during development (<xref ref-type="bibr" rid="bib43">Ramachandran et al., 2022</xref>). Corresponding to the previous report, the mice with the rescued thymus showed no apparent signs of immune deficiency and survived until adulthood (<xref ref-type="bibr" rid="bib59">Yamazaki et al., 2022</xref>). In these complemented mice, immune cells were most likely educated in self-recognition by donor cells’ derived thymus epithelium and induced central tolerance. How thymic epithelium is distinctively lineage labeled by Foxa2 and Shh, and the tolerance difference should be investigated further. It is also important to note that GvHD is a crucial risk factor for long-term survival following human lung transplantation (<xref ref-type="bibr" rid="bib5">Bos et al., 2022</xref>). If we transplant the complemented lungs as a graft containing the conditioned host- and donor-derived immune cells to the recipient that provided donor PSC, it may not cause GvHD. This unique research direction of autologous lung transplantation must be extensively investigated using recipient-derived iPSC with our CBC lung generation models.</p><p>An unambiguous proof of the developmental origins of patterned organs is critical for developing regenerative strategies and a better understanding of the genes responsible for congenital malformations. The human-derived developmental program modification to match the host animals is vital for the future development of whole lung generation via CBC using human iPSCs. More broadly, our studies offer a new paradigm that can be applied to modeling various congenital lung diseases of both lung mesenchyme and epithelium and future autologous transplantation therapies using iPSC in the near future.</p></sec><sec id="s4" sec-type="methods"><title>Methods</title><sec id="s4-1"><title>Mouse</title><p><italic>Shh<sup>Cre/+</sup></italic> mice (cat. 05622), <italic>Rosa26<sup>tdTomato/ tdTomato</sup></italic> mice (cat. 07914), Rosa26<sup>nT-nG/nT-nG</sup> mice (cat. 023035), and <italic>Pdgfra<sup>CreERT2/+</sup></italic> mice (cat. 032770) were obtained from the Jackson Lab. X. Zhang kindly gifted <italic>Fgfr2<sup>flox/flox</sup></italic> mice. We further backcrossed these mice for over three generations with CD-1 mice (cat. 022) from the Charles River. Dr. Nicole C Dubois kindly provided <italic>Foxa2<sup>Cre/Cre</sup></italic> mice (129 × B6 mixed background). For conditional deletion of <italic>Fgfr2</italic> (<italic>Fgfr2</italic> cKO), we crossed <italic>Fgfr2<sup>flox/flox</sup>; Rosa26<sup>tdTomato/tdTomato</sup></italic> females with <italic>Foxa2<sup>Cre/Cre</sup>; Fgfr2<sup>flox/+</sup></italic>, <italic>Foxa2<sup>Cre/+</sup>; Fgfr2<sup>flox/+</sup></italic>, or <italic>Shh<sup>Cre/+</sup>; Fgfr2<sup>flox/+</sup></italic> males, respectively. PCR performed genotyping of the <italic>Shh-Cre</italic>, <italic>Rosa26-tdTomato</italic>, <italic>Rosa26-nTnG</italic>, and <italic>Pdgfra-CreERT2</italic> alleles according to the protocol provided by the vendor. For detecting the <italic>Fgfr2</italic> floxed allele, we performed PCR using the primer sets: 5′-<named-content content-type="sequence">ATAGGAGCAACAGGCGG</named-content>-3′, and 5′-<named-content content-type="sequence">CAAGAGGCGACCAGTCA</named-content>-3′ (<xref ref-type="bibr" rid="bib36">Mori et al., 2019</xref>). For the CBC, genotyping of chimeric animals was confirmed by 10,000 sorted cells from GFP-negative, tdTomato-positive sorted liver or lung cells. Briefly, liver or lung fibroblasts of adult chimeric mice were primarily cultured in Dulbecco’s modified Eagle's medium (DMEM) + 10% fetal bovine serum (FBS) supplemented with penicillin/streptomycin. Then tdTomato<sup>+</sup> cells were sorted out, and genotyping was confirmed. In addition to this, IF imaging of Fgfr2 in tdTomato<sup>+</sup> tracheal epithelial cells was also conducted to confirm Fgfr2 knockout for adult chimera analysis using tyramid signal amplification (AKOYA Biosciences, SAT705A001EA). For lineage tracing with <italic>Pdgfra<sup>CreERT2/+</sup>; Rosa26<sup>tdTomato/+</sup></italic> mice, 1 dose of 200 µg tamoxifen (MedChem Express, HY-13757A) per g of body weight was given via oral gavage injection. All animal experiments were approved by Columbia University Institutional Animal Care and Use Committee in accordance with US National Institutes of Health guidelines.</p></sec><sec id="s4-2"><title>Culture of human PSCs</title><p>All PSC lines were maintained in feeder-free conditions on laminin iMatrix-511 silk E8 (Amsbio, AMS.892021) in StemFit 04 complete Medium (Amsbio, SFB-504), supplemented with Primocin (Invivogen, ant-pm-1), and passaged with TrypLE Select (Gibco, A1285901). All human iPSC lines used were characterized for pluripotency and were found to be karyotypically normal. The BU3NGST cell line was kindly gifted by Dr. Finn Hawkins and Dr. Darrell Kotton at Boston University, Boston, MA. Dr. Jennifer Davis, the University of Washington School of Medicine, Seattle, WA, kindly gifted the Rainbow cell line. PD2 and TD1 hiPSC were generated from deidentified commercially available human peripheral blood mononuclear cell and tracheal epithelial cell lines via the manufacturing protocol of Sendai virus-mediated reprogramming (CytoTune2.0) (Thermo Fisher, A16517) under the CUIMC ESCRO guidelines. Every other month, all iPSC lines screened negative for mycoplasma contamination using a MycoAlert PLUS detection kit (Lonza, LT07-710).</p></sec><sec id="s4-3"><title>Differentiation of hPSCs into lung epithelial and mesenchymal cells</title><p>The directed differentiation protocols were modified from previous protocols to maximize lung mesenchymal cell generation concomitantly with NKX2-1<sup>+</sup> lung epithelium (<xref ref-type="bibr" rid="bib24">Hawkins et al., 2017</xref>; <xref ref-type="bibr" rid="bib26">Huang et al., 2014</xref>). Briefly, DE and LPM precursors were induced once seeded hPSC-formed colonies by the Activin induction using the STEMdiff Definitive Endoderm Kit (StemCell Technologies, 05110) for 72 hr. Differentiated cells were dissociated and passaged in Laminin511-coated tissue culture plates in a complete serum-free differentiation medium (cSFDM) (<xref ref-type="bibr" rid="bib8">Chen et al., 2017</xref>). To induce DE and LPM into the anterior foregut endoderm and mesoderm, the cSFDM was supplemented with 10 µM SB431542 (MedChem Express, HY-10431) and 2 µM Dorsomorphin (Tocris, 3093) for 48 hr and 10 µM SB431542 and 2 µM IWP2 (Tocris, 3533) for 24 hr. Cells were then cultured for 7–10 additional days in cSFDM containing 3 µM CHIR99021, 10 ng/ml recombinant human FGF10 (R&amp;D Systems, 345-FG), 10 ng/ml recombinant human KGF (R&amp;D Systems, 251-KG), 10 ng/ml recombinant human BMP4 (R&amp;D Systems, 314-BP), and 50 nM retinoid acid (Sigma-Aldrich, R2625) to induce NKX2-1 positive lung epithelial cells and WNT2<sup>+</sup>TBX4<sup>+</sup> lung mesenchymal cells.</p></sec><sec id="s4-4"><title>Immunofluorescence</title><p>Before the immunostaining, antigen retrieval was performed using Unmasking Solution (Vector Laboratories, H-3300) for 10 min at around 100°C by microwave. 4–7 µm tissue sections were incubated with primary antibodies in the staining buffer containing 0.025% Triton X-100, and 1% bovine serum albumin (BSA) overnight at 4°C. Mouse primary antibody staining was done using M.O.M kit (Vector Labs, BMK-2202). Then washed in PBS and incubated with secondary antibodies conjugated with Alexa488, 567, or 647 (Thermo Scientific, 1:400) with NucBlue Fixed Cell Ready Probes Reagent (Hoechst) (Thermo Scientific, R37605) for 1.5 hr, and mounted with ProLong Gold antifade reagent (Invitrogen, P36930). The images were captured by a Zeiss confocal 710 microscope or Leica Stellaris 8 confocal microscopy or DMi8 Leica widefield microscope. The antibodies are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>.</p></sec><sec id="s4-5"><title>Immunocytochemistry</title><p>Cells on culture dishes were fixed with 4% paraformaldehyde (PFA) for 30 min at room temperature (RT), permeabilized, and blocked with staining buffer for 1 hr at RT. Primary antibodies were incubated overnight at 4°C in the staining buffer. After three washes in PBS, secondary antibodies and NucBlue Fixed Cell Ready Probes Reagent (Hoechst) were incubated for 1 hr. The samples were imaged using DMi8 Leica widefield microscope. The antibodies are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>.</p></sec><sec id="s4-6"><title>RNAScope in situ hybridization</title><p>RNA at E18.5 lung sections were stained by RNAScope probes: Mm-Foxa2-T8 (Advanced Cell Diagnostics, #409111-T8) or Negative control (NC) (Advanced Cell Diagnostics, #324341) using the RNAScope HiPlex12 Reagent kit v2 (Advanced Cell Diagnostics, #324419) according to manufacture-provided protocol. Subsequently, sections were incubated with tdTomato antibody for 2 hr at RT, washed in PBS, incubated with secondary antibody conjugated with Alexa488 with NucBlue Fixed Cell Ready Probes Reagent (Hoechst) for 1.5 hr, and mounted with ProLong Gold antifade reagent. The images of <italic>Foxa2</italic> and NC in situ hybridization were captured with the same setting by a Zeiss confocal 710 microscope.</p></sec><sec id="s4-7"><title>FCM analyses of mouse lung tissue</title><p>Lungs from lineage-tracing mice at E14.5, E18.5, P0, and 4 weeks or lungs from CBC chimeric mice at E14.5, E17.5, and 4 weeks were harvested and prepared for the FCM, as previously described (<xref ref-type="bibr" rid="bib36">Mori et al., 2019</xref>). Briefly, tissues were minced with microscissors, and incubated in 1 ml of pre-warmed dissociation buffer (1 mg/ml DNase [Sigma, DN25], 5 mg/ml collagen [Roche, 10103578001], and 15 U/ml Dispase II [Stemcell Technologies, 7913]) in Hanks' Balanced Salt Solution (HBSS) at 37°C on the rocker with 80 r.p.m. speed, and then neutralized by FACS buffer containing 2% FBS, Glutamax, 2 mM Ethylenediaminetetraacetic acid (EDTA) and 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) in HBSS after the 30–60 min incubation. After filtrating the cells with a 40 µm filter (FALCON, 352235), cell pellets were resuspended with 1 ml of cold RBC lysis buffer (BioLegend, 420301) to lyse the remaining erythrocytes for 5 min on ice, and neutralized by 1 ml cold FACS buffer. After that, it was centrifuged at 350 rcf, 4°C, for 3 min to remove the lysed blood cells. For FCM analysis, one million cells were transferred in 100 µl of FACS buffer supplemented with 0.5 µM Y27632 and then added 2 µl Fc Block (BD Pharmingen, 553141) per sample followed by 10 min incubation on ice. Cells were incubated with the following antibodies: CD31-APC (BioLegend, 102510, 1/50), Epcam-BV711 (BioLegend, 118233, 1/50), or Epcam-BV421 (BioLegend, 118225, 1/50), Aqua Zombie (BioLegend, 423101, 1/100), CD45-BV605 (BioLegend, 103104, 1/50) for 30 min on ice. After staining, cells were washed twice with FACS buffer before resuspending in 500 µl FACS buffer for the subsequent analyses using SONY MA900 or NovoCyte. Compensation was manually performed to minimize the tdTomato signal leakage to the GFP and BV605 channel using FlowJo (ver. 10. 7. 1). Two samples from E14.5 lineage-tracing mice were removed from analysis based on inaccurate staining of live staining. Total four lungs were calculated from six embryos.</p></sec><sec id="s4-8"><title>Real-time quantitative RT-PCR</title><p>Total RNA was extracted using a Direct-zol RNA MiniPrep Plus kit (Zymo Research, R2072), and cDNA was synthesized using Primescript RT Master Mix (Takara, RR036B). The cDNAs were then used as templates for quantitative RT-PCR analysis with gene-specific primers. Reactions (10 µl) were performed Luna Universal qPCR Master Mix (New England Biolabs, M3003X). mRNA abundance for each gene was determined relative to GAPDH mRNA using the 2<sup>−ΔΔCt</sup> method. The primers are listed in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>. Data were represented as mean ± standard deviation of measurements. The number of animals or cells per group is provided in the legends. The undetected values in each biological experiment in <xref ref-type="fig" rid="fig3">Figure 3D</xref> were removed from the graphs.</p></sec><sec id="s4-9"><title>EdU assay</title><p>100 µg of EdU (Click iT EDU cell proliferation kit, C10337) was injected to pregnant females by intraperitoneal injection 4 hr prior to analysis. Lungs from lineage-tracing mice at E14.5 and E18.5 were harvested and prepared for the FCM. Then cells were fixed by 4% PFA in PBS and stained by the anufacture’s protocol.</p></sec><sec id="s4-10"><title>nGFP<sup>+</sup> iPSC establishment</title><p>E14.5 lung tissues of <italic>Rosa26<sup>nTnG/nTnG</sup></italic> mice were harvested in a dissociation buffer described above. The dissociated cells were seeded on a 10-cm dish, and only lung fibroblast survived after 1 week in Mouse Embryonic Fibroblast (MEF) medium (<xref ref-type="bibr" rid="bib36">Mori et al., 2019</xref>). The fibroblasts were passaged using Accutase (Innovative Cell Technologies, AT104) and seeded on gelatin (Millipore-Sigma, ES006B)-coated 6-well plates with a density of 0.1 million cells per well. Upon cell attachment, Yamanaka reprogramming factors were induced to iPSCs via Sendai virus using CytoTune2.0 (Thermo Fisher, A16517). To establish nGFP<sup>+</sup> iPSCs, the Cre plasmid was transfected using Fugene HD transfection reagent (Promega, E2311), then GFP<sup>+</sup>tdTomato<sup>−</sup> live cells were sorted out by SONY MA900, and single clones were expanded.</p></sec><sec id="s4-11"><title>Culture of mouse PSC and preparation for CBC donor</title><p>For the lung complementation analysis, we injected following PSCs into blastocysts: nGFP<sup>+</sup>iPSC (established in this study), PSC<sup>CAG-GFP</sup> (C57BL/6Nx129S6 background, MTI-GlobalStem: cat. no. GSC-5003). Those PSCs were cultured in a2i/VPA/LIF medium on a feeder, as previously reported (<xref ref-type="bibr" rid="bib36">Mori et al., 2019</xref>). These PSCs were passaged and seeded in 10<sup>5</sup> cells in 6-well plate every 2–3 days. For the CBC donor cell preparation, PSCs were trypsinized 2 min and resuspended in 4 ml cold DMEM + 10% FBS immediately and filtering the cells with a 40 μm filter. Cells were centrifuged at 350 rcf, 4°C, for 3 min, and the supernatant was removed. After being washed with flow buffer containing 0.2% BSA, 1% Glutamax, and 1 µM Y27632, 1 million cells were resuspended in 100 µl flow buffer. The following antibodies were added: Epcam-BV421 (1:50), SSEA1-PE (1:20), CD31-APC (1:20), and Zombie Aqua Fixable Viability Kit (1:100). Epcam<sup>high</sup>SSEA1<sup>high</sup>CD31<sup>high</sup> cells were sorted by SONY MA900 and subsequently prepared for the injection.</p></sec><sec id="s4-12"><title>Blastocyst preparation and embryo transfer</title><p>Blastocysts were prepared by mating <italic>Foxa2<sup>Cre/Cre</sup>; Fgfr2<sup>flox/+</sup></italic>, <italic>Foxa2<sup>Cre/+</sup>; Fgfr2<sup>flox/+</sup></italic>, or <italic>Shh<sup>Cre/+</sup>; Fgfr2<sup>flox/+</sup></italic> males (all 129 × B6 × CD-1 background) with superovulated Fgfr2<sup>flox/flox</sup>; Rosa26<sup>tdTomato/tdTomato</sup> females (129 × B6 × CD-1 background). Blastocysts were harvested at E3.5 after superovulation (<xref ref-type="bibr" rid="bib36">Mori et al., 2019</xref>). Twenty sorted PSCs were injected into each blastocyst. After the PSC injection, blastocysts were cultured in an M2 medium (Cosmobio) for a few hours in a 37°C, 5% CO<sub>2</sub> incubator for recovery. Then, blastocysts were transferred to the uterus of the pseudopregnant foster mother (see <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>).</p></sec><sec id="s4-13"><title>Respiratory function analysis</title><p>Respiratory function was measured in 4 weeks chimeric mutant mice (<italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> cKO<italic>; Rosa<sup>tdTomato</sup></italic> or <italic>Foxa2<sup>Cre/+</sup>; Fgfr2</italic> hetero<italic>; Rosa<sup>tdTomato</sup></italic> injected with PSC<sup>CAG-GFP</sup>) using Buxco FinePointe NAM 2-SiteStaion (DSI) with non-invasive technique (<xref ref-type="bibr" rid="bib40">Pennock et al., 1979</xref>). Values for all measurements represent an average of 5 min monitoring with no rejection index.</p></sec><sec id="s4-14"><title>Morphometric analysis</title><p>To determine the relative number of specific cell populations, 5 non-overlapping random fields per mouse were analyzed (×40 magnification) after capturing the images by confocal microscopes (see above). We counted the number of GFP<sup>+</sup> cells or tdTomato<sup>+</sup> cells co-immunostained with specific antibodies for each field. Hoechst co-staining was used to determine the cell number for each lineage as identified by differentiation markers. Those analyses were processed using ImageJ (NIH).</p></sec><sec id="s4-15"><title>Statistical analysis</title><p>Data analysis was performed using Prism 8. Data acquired by performing biological replicas of two or three independent experiments are presented as the mean ± SD. Statistical significance was determined using a two-tailed <italic>t</italic>-test and unpaired one- or two-way analysis of variance with the Tukey post hoc test. *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001, ****p &lt; 0.0001, ns: non-significant.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Formal analysis, Validation, Investigation, Visualization, Methodology, Writing – original draft</p></fn><fn fn-type="con" id="con2"><p>Investigation</p></fn><fn fn-type="con" id="con3"><p>Investigation</p></fn><fn fn-type="con" id="con4"><p>Investigation</p></fn><fn fn-type="con" id="con5"><p>Investigation</p></fn><fn fn-type="con" id="con6"><p>Investigation</p></fn><fn fn-type="con" id="con7"><p>Investigation</p></fn><fn fn-type="con" id="con8"><p>Investigation</p></fn><fn fn-type="con" id="con9"><p>Resources, Investigation</p></fn><fn fn-type="con" id="con10"><p>Investigation</p></fn><fn fn-type="con" id="con11"><p>Investigation</p></fn><fn fn-type="con" id="con12"><p>Investigation</p></fn><fn fn-type="con" id="con13"><p>Resources</p></fn><fn fn-type="con" id="con14"><p>Resources</p></fn><fn fn-type="con" id="con15"><p>Investigation</p></fn><fn fn-type="con" id="con16"><p>Resources</p></fn><fn fn-type="con" id="con17"><p>Investigation</p></fn><fn fn-type="con" id="con18"><p>Resources</p></fn><fn fn-type="con" id="con19"><p>Investigation</p></fn><fn fn-type="con" id="con20"><p>Conceptualization, Data curation, Supervision, Funding acquisition, Validation, Investigation, Methodology, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All works using human iPSC lines are derived from deidentified materials here were conducted under the approval of the ethical committee meeting at Columbia University Medical Canter without the requirement of IRB.</p></fn><fn fn-type="other"><p>All animal experiments were approved by Columbia University Institutional Animal Care and Use Committee protocols (AABF8554) in accordance with US National Institutes of Health guidelines.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-86105-mdarchecklist1-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>The antibody list used for the immunostainings and flowcytometry analyses in this article.</title></caption><media xlink:href="elife-86105-supp1-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>The primer list used for qPCR analysis in the article.</title></caption><media xlink:href="elife-86105-supp2-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>Summary of PSC donor lines, culture conditions, host mouse strains, and data for chimera formation, lung complementation, and survival in mice subjected to CBC.</title></caption><media xlink:href="elife-86105-supp3-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>scRNA-seq data for mouse gastrulation and early organogenesis described in the manuscript have been analyzed from the deposited database at <ext-link ext-link-type="uri" xlink:href="https://marionilab.cruk.cam.ac.uk/MouseGastrulation2018/">https://marionilab.cruk.cam.ac.uk/MouseGastrulation2018/</ext-link>. The authors declare that all data supporting the results of this study are available within the paper and the supplementary files.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Zurab Ninish for his technical assistance. We sincerely appreciate the generous support from Dr. Hiromitsu Nakauchi at Stanford University and the considerate support and scientific input from Dr. Wellington Cardoso at the Columbia Center for Human Development (CCHD) and the members of Cardoso’s lab and CCHD. We acknowledge the support from the CCHD Medicine Microscopy core (MMC) (NIH S10 OD032447-01), Columbia Stem Cell Initiative (CSCI) Flow Cytometry core, and Genetically Modified Mouse Model Shared Resource (GMMMSR) (P30CA013696) for blastocyst injection. We thank Dr. Heiko Lickert of the Technical University of Munich (TUM) for sharing Foxa2-Cre mice. This work was funded by NIH-NHLBI 1R01 HL148223-01, DoD PR190557, PR191133 to MM, JSPS202080340, and The Uehara Memorial Foundation to AM.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arman</surname><given-names>E</given-names></name><name><surname>Haffner-Krausz</surname><given-names>R</given-names></name><name><surname>Gorivodsky</surname><given-names>M</given-names></name><name><surname>Lonai</surname><given-names>P</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Fgfr2 is required for limb outgrowth and lung-branching morphogenesis</article-title><source>PNAS</source><volume>96</volume><fpage>11895</fpage><lpage>11899</lpage><pub-id pub-id-type="doi">10.1073/pnas.96.21.11895</pub-id><pub-id pub-id-type="pmid">10518547</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Artus</surname><given-names>J</given-names></name><name><surname>Panthier</surname><given-names>JJ</given-names></name><name><surname>Hadjantonakis</surname><given-names>AK</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A role for PDGF signaling in expansion of the extra-embryonic endoderm lineage of the mouse blastocyst</article-title><source>Development</source><volume>137</volume><fpage>3361</fpage><lpage>3372</lpage><pub-id pub-id-type="doi">10.1242/dev.050864</pub-id><pub-id pub-id-type="pmid">20826533</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bardot</surname><given-names>E</given-names></name><name><surname>Calderon</surname><given-names>D</given-names></name><name><surname>Santoriello</surname><given-names>F</given-names></name><name><surname>Han</surname><given-names>S</given-names></name><name><surname>Cheung</surname><given-names>K</given-names></name><name><surname>Jadhav</surname><given-names>B</given-names></name><name><surname>Burtscher</surname><given-names>I</given-names></name><name><surname>Artap</surname><given-names>S</given-names></name><name><surname>Jain</surname><given-names>R</given-names></name><name><surname>Epstein</surname><given-names>J</given-names></name><name><surname>Lickert</surname><given-names>H</given-names></name><name><surname>Gouon-Evans</surname><given-names>V</given-names></name><name><surname>Sharp</surname><given-names>AJ</given-names></name><name><surname>Dubois</surname><given-names>NC</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Foxa2 identifies a cardiac progenitor population with ventricular differentiation potential</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>14428</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms14428</pub-id><pub-id pub-id-type="pmid">28195173</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bates</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Role of fibroblast growth factor receptor signaling in kidney development</article-title><source>Am J Physiol Ren Physiol</source><volume>301</volume><fpage>245</fpage><lpage>251</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00186.2011.-Fibroblast</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bos</surname><given-names>S</given-names></name><name><surname>Beeckmans</surname><given-names>H</given-names></name><name><surname>Vanstapel</surname><given-names>A</given-names></name><name><surname>Sacreas</surname><given-names>A</given-names></name><name><surname>Geudens</surname><given-names>V</given-names></name><name><surname>Willems</surname><given-names>L</given-names></name><name><surname>Schreurs</surname><given-names>I</given-names></name><name><surname>Vanaudenaerde</surname><given-names>BM</given-names></name><name><surname>Schoemans</surname><given-names>H</given-names></name><name><surname>Vos</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Pulmonary graft-versus-host disease and chronic lung allograft dysfunction: two sides of the same coin?</article-title><source>The Lancet. Respiratory Medicine</source><volume>10</volume><fpage>796</fpage><lpage>810</lpage><pub-id pub-id-type="doi">10.1016/S2213-2600(22)00001-7</pub-id><pub-id pub-id-type="pmid">35512715</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cardoso</surname><given-names>WV</given-names></name><name><surname>Kotton</surname><given-names>DN</given-names></name></person-group><year iso-8601-date="2008">2008</year><chapter-title>Specification and patterning of the respiratory system</chapter-title><source>StemBook</source><publisher-name>IOS Press</publisher-name><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.3824/stembook.1.10.1</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Lansford</surname><given-names>R</given-names></name><name><surname>Stewart</surname><given-names>V</given-names></name><name><surname>Young</surname><given-names>F</given-names></name><name><surname>Alt</surname><given-names>FW</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>RAG-2-deficient blastocyst complementation: an assay of gene function in lymphocyte development</article-title><source>PNAS</source><volume>90</volume><fpage>4528</fpage><lpage>4532</lpage><pub-id pub-id-type="doi">10.1073/pnas.90.10.4528</pub-id><pub-id pub-id-type="pmid">8506294</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>YW</given-names></name><name><surname>Huang</surname><given-names>SX</given-names></name><name><surname>de Carvalho</surname><given-names>A</given-names></name><name><surname>Ho</surname><given-names>SH</given-names></name><name><surname>Islam</surname><given-names>MN</given-names></name><name><surname>Volpi</surname><given-names>S</given-names></name><name><surname>Notarangelo</surname><given-names>LD</given-names></name><name><surname>Ciancanelli</surname><given-names>M</given-names></name><name><surname>Casanova</surname><given-names>JL</given-names></name><name><surname>Bhattacharya</surname><given-names>J</given-names></name><name><surname>Liang</surname><given-names>AF</given-names></name><name><surname>Palermo</surname><given-names>LM</given-names></name><name><surname>Porotto</surname><given-names>M</given-names></name><name><surname>Moscona</surname><given-names>A</given-names></name><name><surname>Snoeck</surname><given-names>HW</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A three-dimensional model of human lung development and disease from pluripotent stem cells</article-title><source>Nature Cell Biology</source><volume>19</volume><fpage>542</fpage><lpage>549</lpage><pub-id pub-id-type="doi">10.1038/ncb3510</pub-id><pub-id pub-id-type="pmid">28436965</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chhatta</surname><given-names>A</given-names></name><name><surname>Mikkers</surname><given-names>HMM</given-names></name><name><surname>Staal</surname><given-names>FJT</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Strategies for thymus regeneration and generating thymic organoids</article-title><source>Journal of Immunology and Regenerative Medicine</source><volume>14</volume><elocation-id>100052</elocation-id><pub-id pub-id-type="doi">10.1016/j.regen.2021.100052</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christodoulou</surname><given-names>C</given-names></name><name><surname>Longmire</surname><given-names>TA</given-names></name><name><surname>Shen</surname><given-names>SS</given-names></name><name><surname>Bourdon</surname><given-names>A</given-names></name><name><surname>Sommer</surname><given-names>CA</given-names></name><name><surname>Gadue</surname><given-names>P</given-names></name><name><surname>Spira</surname><given-names>A</given-names></name><name><surname>Gouon-Evans</surname><given-names>V</given-names></name><name><surname>Murphy</surname><given-names>GJ</given-names></name><name><surname>Mostoslavsky</surname><given-names>G</given-names></name><name><surname>Kotton</surname><given-names>DN</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Mouse ES and iPS cells can form similar definitive endoderm despite differences in imprinted genes</article-title><source>The Journal of Clinical Investigation</source><volume>121</volume><fpage>2313</fpage><lpage>2325</lpage><pub-id pub-id-type="doi">10.1172/JCI43853</pub-id><pub-id pub-id-type="pmid">21537085</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crapo</surname><given-names>JD</given-names></name><name><surname>Barry</surname><given-names>BE</given-names></name><name><surname>Gehr</surname><given-names>P</given-names></name><name><surname>Bachofen</surname><given-names>M</given-names></name><name><surname>Weibel</surname><given-names>ER</given-names></name></person-group><year iso-8601-date="1982">1982</year><article-title>Cell number and cell characteristics of the normal human lung</article-title><source>The American Review of Respiratory Disease</source><volume>126</volume><fpage>332</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1164/arrd.1982.126.2.332</pub-id><pub-id pub-id-type="pmid">7103258</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Langhe</surname><given-names>SP</given-names></name><name><surname>Carraro</surname><given-names>G</given-names></name><name><surname>Warburton</surname><given-names>D</given-names></name><name><surname>Hajihosseini</surname><given-names>MK</given-names></name><name><surname>Bellusci</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Levels of mesenchymal FGFR2 signaling modulate smooth muscle progenitor cell commitment in the lung</article-title><source>Developmental Biology</source><volume>299</volume><fpage>52</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2006.07.001</pub-id><pub-id pub-id-type="pmid">16989802</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Moerlooze</surname><given-names>L</given-names></name><name><surname>Spencer-Dene</surname><given-names>B</given-names></name><name><surname>Revest</surname><given-names>JM</given-names></name><name><surname>Hajihosseini</surname><given-names>M</given-names></name><name><surname>Rosewell</surname><given-names>I</given-names></name><name><surname>Dickson</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis</article-title><source>Development</source><volume>127</volume><fpage>483</fpage><lpage>492</lpage><pub-id pub-id-type="doi">10.1242/dev.127.3.483</pub-id><pub-id pub-id-type="pmid">10631169</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devine</surname><given-names>WP</given-names></name><name><surname>Wythe</surname><given-names>JD</given-names></name><name><surname>George</surname><given-names>M</given-names></name><name><surname>Koshiba-Takeuchi</surname><given-names>K</given-names></name><name><surname>Bruneau</surname><given-names>BG</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Early patterning and specification of cardiac progenitors in gastrulating mesoderm</article-title><source>eLife</source><volume>3</volume><elocation-id>e03848</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.03848</pub-id><pub-id pub-id-type="pmid">25296024</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dooley</surname><given-names>J</given-names></name><name><surname>Erickson</surname><given-names>M</given-names></name><name><surname>Larochelle</surname><given-names>WJ</given-names></name><name><surname>Gillard</surname><given-names>GO</given-names></name><name><surname>Farr</surname><given-names>AG</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>FGFR2IIIb signaling regulates thymic epithelial differentiation</article-title><source>Developmental Dynamics</source><volume>236</volume><fpage>3459</fpage><lpage>3471</lpage><pub-id pub-id-type="doi">10.1002/dvdy.21364</pub-id><pub-id pub-id-type="pmid">17969154</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gotoh</surname><given-names>S</given-names></name><name><surname>Ito</surname><given-names>I</given-names></name><name><surname>Nagasaki</surname><given-names>T</given-names></name><name><surname>Yamamoto</surname><given-names>Y</given-names></name><name><surname>Konishi</surname><given-names>S</given-names></name><name><surname>Korogi</surname><given-names>Y</given-names></name><name><surname>Matsumoto</surname><given-names>H</given-names></name><name><surname>Muro</surname><given-names>S</given-names></name><name><surname>Hirai</surname><given-names>T</given-names></name><name><surname>Funato</surname><given-names>M</given-names></name><name><surname>Mae</surname><given-names>SI</given-names></name><name><surname>Toyoda</surname><given-names>T</given-names></name><name><surname>Sato-Otsubo</surname><given-names>A</given-names></name><name><surname>Ogawa</surname><given-names>S</given-names></name><name><surname>Osafune</surname><given-names>K</given-names></name><name><surname>Mishima</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Generation of alveolar epithelial spheroids via isolated progenitor cells from human pluripotent stem cells</article-title><source>Stem Cell Reports</source><volume>3</volume><fpage>394</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2014.07.005</pub-id><pub-id pub-id-type="pmid">25241738</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>MD</given-names></name><name><surname>Chen</surname><given-names>A</given-names></name><name><surname>Nostro</surname><given-names>M-C</given-names></name><name><surname>d’Souza</surname><given-names>SL</given-names></name><name><surname>Schaniel</surname><given-names>C</given-names></name><name><surname>Lemischka</surname><given-names>IR</given-names></name><name><surname>Gouon-Evans</surname><given-names>V</given-names></name><name><surname>Keller</surname><given-names>G</given-names></name><name><surname>Snoeck</surname><given-names>H-W</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Generation of anterior foregut endoderm from human embryonic and induced pluripotent stem cells</article-title><source>Nature Biotechnology</source><volume>29</volume><fpage>267</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1038/nbt.1788</pub-id><pub-id pub-id-type="pmid">21358635</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guyette</surname><given-names>JP</given-names></name><name><surname>Gilpin</surname><given-names>SE</given-names></name><name><surname>Charest</surname><given-names>JM</given-names></name><name><surname>Tapias</surname><given-names>LF</given-names></name><name><surname>Ren</surname><given-names>X</given-names></name><name><surname>Ott</surname><given-names>HC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Perfusion decellularization of whole organs</article-title><source>Nature Protocols</source><volume>9</volume><fpage>1451</fpage><lpage>1468</lpage><pub-id pub-id-type="doi">10.1038/nprot.2014.097</pub-id><pub-id pub-id-type="pmid">24874812</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hackett</surname><given-names>TL</given-names></name><name><surname>Knight</surname><given-names>DA</given-names></name><name><surname>Sin</surname><given-names>DD</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Potential role of stem cells in management of COPD</article-title><source>International Journal of Chronic Obstructive Pulmonary Disease</source><volume>5</volume><fpage>81</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.2147/copd.s7373</pub-id><pub-id pub-id-type="pmid">20463889</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamanaka</surname><given-names>S</given-names></name><name><surname>Umino</surname><given-names>A</given-names></name><name><surname>Sato</surname><given-names>H</given-names></name><name><surname>Hayama</surname><given-names>T</given-names></name><name><surname>Yanagida</surname><given-names>A</given-names></name><name><surname>Mizuno</surname><given-names>N</given-names></name><name><surname>Kobayashi</surname><given-names>T</given-names></name><name><surname>Kasai</surname><given-names>M</given-names></name><name><surname>Suchy</surname><given-names>FP</given-names></name><name><surname>Yamazaki</surname><given-names>S</given-names></name><name><surname>Masaki</surname><given-names>H</given-names></name><name><surname>Yamaguchi</surname><given-names>T</given-names></name><name><surname>Nakauchi</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Generation of vascular endothelial cells and hematopoietic cells by blastocyst complementation</article-title><source>Stem Cell Reports</source><volume>11</volume><fpage>988</fpage><lpage>997</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2018.08.015</pub-id><pub-id pub-id-type="pmid">30245211</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>L</given-names></name><name><surname>Chaturvedi</surname><given-names>P</given-names></name><name><surname>Kishimoto</surname><given-names>K</given-names></name><name><surname>Koike</surname><given-names>H</given-names></name><name><surname>Nasr</surname><given-names>T</given-names></name><name><surname>Iwasawa</surname><given-names>K</given-names></name><name><surname>Giesbrecht</surname><given-names>K</given-names></name><name><surname>Witcher</surname><given-names>PC</given-names></name><name><surname>Eicher</surname><given-names>A</given-names></name><name><surname>Haines</surname><given-names>L</given-names></name><name><surname>Lee</surname><given-names>Y</given-names></name><name><surname>Shannon</surname><given-names>JM</given-names></name><name><surname>Morimoto</surname><given-names>M</given-names></name><name><surname>Wells</surname><given-names>JM</given-names></name><name><surname>Takebe</surname><given-names>T</given-names></name><name><surname>Zorn</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single cell transcriptomics identifies a signaling network coordinating endoderm and mesoderm diversification during foregut organogenesis</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>4158</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-17968-x</pub-id><pub-id pub-id-type="pmid">32855417</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>KS</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>McManus</surname><given-names>MT</given-names></name><name><surname>Harfe</surname><given-names>BD</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Dicer function is essential for lung epithelium morphogenesis</article-title><source>PNAS</source><volume>103</volume><fpage>2208</fpage><lpage>2213</lpage><pub-id pub-id-type="doi">10.1073/pnas.0510839103</pub-id><pub-id pub-id-type="pmid">16452165</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hart</surname><given-names>AH</given-names></name><name><surname>Hartley</surname><given-names>L</given-names></name><name><surname>Sourris</surname><given-names>K</given-names></name><name><surname>Stadler</surname><given-names>ES</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Stanley</surname><given-names>EG</given-names></name><name><surname>Tam</surname><given-names>PPL</given-names></name><name><surname>Elefanty</surname><given-names>AG</given-names></name><name><surname>Robb</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title><italic>Mixl1</italic>        is required for axial mesendoderm morphogenesis and patterning in the murine embryo</article-title><source>Development</source><volume>129</volume><fpage>3597</fpage><lpage>3608</lpage><pub-id pub-id-type="doi">10.1242/dev.129.15.3597</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawkins</surname><given-names>F</given-names></name><name><surname>Kramer</surname><given-names>P</given-names></name><name><surname>Jacob</surname><given-names>A</given-names></name><name><surname>Driver</surname><given-names>I</given-names></name><name><surname>Thomas</surname><given-names>DC</given-names></name><name><surname>McCauley</surname><given-names>KB</given-names></name><name><surname>Skvir</surname><given-names>N</given-names></name><name><surname>Crane</surname><given-names>AM</given-names></name><name><surname>Kurmann</surname><given-names>AA</given-names></name><name><surname>Hollenberg</surname><given-names>AN</given-names></name><name><surname>Nguyen</surname><given-names>S</given-names></name><name><surname>Wong</surname><given-names>BG</given-names></name><name><surname>Khalil</surname><given-names>AS</given-names></name><name><surname>Huang</surname><given-names>SX</given-names></name><name><surname>Guttentag</surname><given-names>S</given-names></name><name><surname>Rock</surname><given-names>JR</given-names></name><name><surname>Shannon</surname><given-names>JM</given-names></name><name><surname>Davis</surname><given-names>BR</given-names></name><name><surname>Kotton</surname><given-names>DN</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Prospective isolation of NKX2-1-expressing human lung progenitors derived from pluripotent stem cells</article-title><source>The Journal of Clinical Investigation</source><volume>127</volume><fpage>2277</fpage><lpage>2294</lpage><pub-id pub-id-type="doi">10.1172/JCI89950</pub-id><pub-id pub-id-type="pmid">28463226</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horn</surname><given-names>S</given-names></name><name><surname>Kobberup</surname><given-names>S</given-names></name><name><surname>Jørgensen</surname><given-names>MC</given-names></name><name><surname>Kalisz</surname><given-names>M</given-names></name><name><surname>Klein</surname><given-names>T</given-names></name><name><surname>Kageyama</surname><given-names>R</given-names></name><name><surname>Gegg</surname><given-names>M</given-names></name><name><surname>Lickert</surname><given-names>H</given-names></name><name><surname>Lindner</surname><given-names>J</given-names></name><name><surname>Magnuson</surname><given-names>MA</given-names></name><name><surname>Kong</surname><given-names>YY</given-names></name><name><surname>Serup</surname><given-names>P</given-names></name><name><surname>Ahnfelt-Rønne</surname><given-names>J</given-names></name><name><surname>Jensen</surname><given-names>JN</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Mind bomb 1 is required for pancreatic β-cell formation</article-title><source>PNAS</source><volume>109</volume><fpage>7356</fpage><lpage>7361</lpage><pub-id pub-id-type="doi">10.1073/pnas.1203605109</pub-id><pub-id pub-id-type="pmid">22529374</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>SXL</given-names></name><name><surname>Islam</surname><given-names>MN</given-names></name><name><surname>O’Neill</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>Y-G</given-names></name><name><surname>Chen</surname><given-names>Y-W</given-names></name><name><surname>Mumau</surname><given-names>M</given-names></name><name><surname>Green</surname><given-names>MD</given-names></name><name><surname>Vunjak-Novakovic</surname><given-names>G</given-names></name><name><surname>Bhattacharya</surname><given-names>J</given-names></name><name><surname>Snoeck</surname><given-names>H-W</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Efficient generation of lung and airway epithelial cells from human pluripotent stem cells</article-title><source>Nature Biotechnology</source><volume>32</volume><fpage>84</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1038/nbt.2754</pub-id><pub-id pub-id-type="pmid">24291815</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kadzik</surname><given-names>RS</given-names></name><name><surname>Morrisey</surname><given-names>EE</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Directing lung endoderm differentiation in pluripotent stem cells</article-title><source>Cell Stem Cell</source><volume>10</volume><fpage>355</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2012.03.013</pub-id><pub-id pub-id-type="pmid">22482501</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kemter</surname><given-names>E</given-names></name><name><surname>Schnieke</surname><given-names>A</given-names></name><name><surname>Fischer</surname><given-names>K</given-names></name><name><surname>Cowan</surname><given-names>PJ</given-names></name><name><surname>Wolf</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Xeno-organ donor pigs with multiple genetic modifications - the more the better?</article-title><source>Current Opinion in Genetics &amp; Development</source><volume>64</volume><fpage>60</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/j.gde.2020.05.034</pub-id><pub-id pub-id-type="pmid">32619817</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kishimoto</surname><given-names>K</given-names></name><name><surname>Furukawa</surname><given-names>KT</given-names></name><name><surname>Luz-Madrigal</surname><given-names>A</given-names></name><name><surname>Yamaoka</surname><given-names>A</given-names></name><name><surname>Matsuoka</surname><given-names>C</given-names></name><name><surname>Habu</surname><given-names>M</given-names></name><name><surname>Alev</surname><given-names>C</given-names></name><name><surname>Zorn</surname><given-names>AM</given-names></name><name><surname>Morimoto</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Bidirectional Wnt signaling between endoderm and mesoderm confers tracheal identity in mouse and human cells</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>4159</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-17969-w</pub-id><pub-id pub-id-type="pmid">32855415</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitahara</surname><given-names>A</given-names></name><name><surname>Ran</surname><given-names>Q</given-names></name><name><surname>Oda</surname><given-names>K</given-names></name><name><surname>Yasue</surname><given-names>A</given-names></name><name><surname>Abe</surname><given-names>M</given-names></name><name><surname>Ye</surname><given-names>X</given-names></name><name><surname>Sasaoka</surname><given-names>T</given-names></name><name><surname>Tsuchida</surname><given-names>M</given-names></name><name><surname>Sakimura</surname><given-names>K</given-names></name><name><surname>Ajioka</surname><given-names>Y</given-names></name><name><surname>Saijo</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Generation of lungs by blastocyst complementation in apneumic Fgf10-deficient mice</article-title><source>Cell Reports</source><volume>31</volume><elocation-id>107626</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.107626</pub-id><pub-id pub-id-type="pmid">32402288</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>T</given-names></name><name><surname>Yamaguchi</surname><given-names>T</given-names></name><name><surname>Hamanaka</surname><given-names>S</given-names></name><name><surname>Kato-Itoh</surname><given-names>M</given-names></name><name><surname>Yamazaki</surname><given-names>Y</given-names></name><name><surname>Ibata</surname><given-names>M</given-names></name><name><surname>Sato</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>Y-S</given-names></name><name><surname>Usui</surname><given-names>J</given-names></name><name><surname>Knisely</surname><given-names>AS</given-names></name><name><surname>Hirabayashi</surname><given-names>M</given-names></name><name><surname>Nakauchi</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Generation of rat pancreas in mouse by interspecific blastocyst injection of pluripotent stem cells</article-title><source>Cell</source><volume>142</volume><fpage>787</fpage><lpage>799</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.07.039</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konishi</surname><given-names>S</given-names></name><name><surname>Gotoh</surname><given-names>S</given-names></name><name><surname>Tateishi</surname><given-names>K</given-names></name><name><surname>Yamamoto</surname><given-names>Y</given-names></name><name><surname>Korogi</surname><given-names>Y</given-names></name><name><surname>Nagasaki</surname><given-names>T</given-names></name><name><surname>Matsumoto</surname><given-names>H</given-names></name><name><surname>Muro</surname><given-names>S</given-names></name><name><surname>Hirai</surname><given-names>T</given-names></name><name><surname>Ito</surname><given-names>I</given-names></name><name><surname>Tsukita</surname><given-names>S</given-names></name><name><surname>Mishima</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Directed induction of functional multi-ciliated cells in proximal airway epithelial spheroids from human pluripotent stem cells</article-title><source>Stem Cell Reports</source><volume>6</volume><fpage>18</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2015.11.010</pub-id><pub-id pub-id-type="pmid">26724905</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kopper</surname><given-names>O</given-names></name><name><surname>Benvenisty</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Stepwise differentiation of human embryonic stem cells into early endoderm derivatives and their molecular characterization</article-title><source>Stem Cell Research</source><volume>8</volume><fpage>335</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1016/j.scr.2011.12.006</pub-id><pub-id pub-id-type="pmid">22286009</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kotton</surname><given-names>DN</given-names></name><name><surname>Morrisey</surname><given-names>EE</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Lung regeneration: mechanisms, applications and emerging stem cell populations</article-title><source>Nature Medicine</source><volume>20</volume><fpage>822</fpage><lpage>832</lpage><pub-id pub-id-type="doi">10.1038/nm.3642</pub-id><pub-id pub-id-type="pmid">25100528</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loh</surname><given-names>KMM</given-names></name><name><surname>Chen</surname><given-names>A</given-names></name><name><surname>Koh</surname><given-names>PWW</given-names></name><name><surname>Deng</surname><given-names>TZZ</given-names></name><name><surname>Sinha</surname><given-names>R</given-names></name><name><surname>Tsai</surname><given-names>JMM</given-names></name><name><surname>Barkal</surname><given-names>AAA</given-names></name><name><surname>Shen</surname><given-names>KYY</given-names></name><name><surname>Jain</surname><given-names>R</given-names></name><name><surname>Morganti</surname><given-names>RMM</given-names></name><name><surname>Shyh-Chang</surname><given-names>N</given-names></name><name><surname>Fernhoff</surname><given-names>NBB</given-names></name><name><surname>George</surname><given-names>BMM</given-names></name><name><surname>Wernig</surname><given-names>G</given-names></name><name><surname>Salomon</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Vogel</surname><given-names>H</given-names></name><name><surname>Epstein</surname><given-names>JAA</given-names></name><name><surname>Kundaje</surname><given-names>A</given-names></name><name><surname>Talbot</surname><given-names>WSS</given-names></name><name><surname>Beachy</surname><given-names>PAA</given-names></name><name><surname>Ang</surname><given-names>LTT</given-names></name><name><surname>Weissman</surname><given-names>ILL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mapping the pairwise choices leading from pluripotency to human bone, heart, and other mesoderm cell types</article-title><source>Cell</source><volume>166</volume><fpage>451</fpage><lpage>467</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.06.011</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>M</given-names></name><name><surname>Furuhashi</surname><given-names>K</given-names></name><name><surname>Danielsson</surname><given-names>JA</given-names></name><name><surname>Hirata</surname><given-names>Y</given-names></name><name><surname>Kakiuchi</surname><given-names>M</given-names></name><name><surname>Lin</surname><given-names>C-S</given-names></name><name><surname>Ohta</surname><given-names>M</given-names></name><name><surname>Riccio</surname><given-names>P</given-names></name><name><surname>Takahashi</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Emala</surname><given-names>CW</given-names></name><name><surname>Lu</surname><given-names>C</given-names></name><name><surname>Nakauchi</surname><given-names>H</given-names></name><name><surname>Cardoso</surname><given-names>WV</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Generation of functional lungs via conditional blastocyst complementation using pluripotent stem cells</article-title><source>Nature Medicine</source><volume>25</volume><fpage>1691</fpage><lpage>1698</lpage><pub-id pub-id-type="doi">10.1038/s41591-019-0635-8</pub-id><pub-id pub-id-type="pmid">31700187</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>WH</given-names></name><name><surname>Johnston</surname><given-names>EK</given-names></name><name><surname>Tan</surname><given-names>JJ</given-names></name><name><surname>Bliley</surname><given-names>JM</given-names></name><name><surname>Feinberg</surname><given-names>AW</given-names></name><name><surname>Stolz</surname><given-names>DB</given-names></name><name><surname>Sun</surname><given-names>M</given-names></name><name><surname>Wijesekara</surname><given-names>P</given-names></name><name><surname>Hawkins</surname><given-names>F</given-names></name><name><surname>Kotton</surname><given-names>DN</given-names></name><name><surname>Ren</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Recapitulating human cardio-pulmonary co-development using simultaneous multilineage differentiation of pluripotent stem cells</article-title><source>eLife</source><volume>11</volume><elocation-id>e67872</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.67872</pub-id><pub-id pub-id-type="pmid">35018887</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ott</surname><given-names>HC</given-names></name><name><surname>Clippinger</surname><given-names>B</given-names></name><name><surname>Conrad</surname><given-names>C</given-names></name><name><surname>Schuetz</surname><given-names>C</given-names></name><name><surname>Pomerantseva</surname><given-names>I</given-names></name><name><surname>Ikonomou</surname><given-names>L</given-names></name><name><surname>Kotton</surname><given-names>D</given-names></name><name><surname>Vacanti</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Regeneration and orthotopic transplantation of a bioartificial lung</article-title><source>Nature Medicine</source><volume>16</volume><fpage>927</fpage><lpage>933</lpage><pub-id pub-id-type="doi">10.1038/nm.2193</pub-id><pub-id pub-id-type="pmid">20628374</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>T</given-names></name><name><surname>Tian</surname><given-names>Y</given-names></name><name><surname>Boogerd</surname><given-names>CJ</given-names></name><name><surname>Lu</surname><given-names>MM</given-names></name><name><surname>Kadzik</surname><given-names>RS</given-names></name><name><surname>Stewart</surname><given-names>KM</given-names></name><name><surname>Evans</surname><given-names>SM</given-names></name><name><surname>Morrisey</surname><given-names>EE</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Coordination of heart and lung co-development by a multipotent cardiopulmonary progenitor</article-title><source>Nature</source><volume>500</volume><fpage>589</fpage><lpage>592</lpage><pub-id pub-id-type="doi">10.1038/nature12358</pub-id><pub-id pub-id-type="pmid">23873040</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pennock</surname><given-names>BE</given-names></name><name><surname>Cox</surname><given-names>CP</given-names></name><name><surname>Rogers</surname><given-names>RM</given-names></name><name><surname>Cain</surname><given-names>WA</given-names></name><name><surname>Wells</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="1979">1979</year><article-title>A noninvasive technique for measurement of changes in specific airway resistance</article-title><source>Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology</source><volume>46</volume><fpage>399</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.1152/jappl.1979.46.2.399</pub-id><pub-id pub-id-type="pmid">422457</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petersen</surname><given-names>TH</given-names></name><name><surname>Calle</surname><given-names>EA</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Lee</surname><given-names>EJ</given-names></name><name><surname>Gui</surname><given-names>L</given-names></name><name><surname>Raredon</surname><given-names>MB</given-names></name><name><surname>Gavrilov</surname><given-names>K</given-names></name><name><surname>Yi</surname><given-names>T</given-names></name><name><surname>Zhuang</surname><given-names>ZW</given-names></name><name><surname>Breuer</surname><given-names>C</given-names></name><name><surname>Herzog</surname><given-names>E</given-names></name><name><surname>Niklason</surname><given-names>LE</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Tissue-engineered lungs for in vivo implantation</article-title><source>Science</source><volume>329</volume><fpage>538</fpage><lpage>541</lpage><pub-id pub-id-type="doi">10.1126/science.1189345</pub-id><pub-id pub-id-type="pmid">20576850</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pijuan-Sala</surname><given-names>B</given-names></name><name><surname>Griffiths</surname><given-names>JA</given-names></name><name><surname>Guibentif</surname><given-names>C</given-names></name><name><surname>Hiscock</surname><given-names>TW</given-names></name><name><surname>Jawaid</surname><given-names>W</given-names></name><name><surname>Calero-Nieto</surname><given-names>FJ</given-names></name><name><surname>Mulas</surname><given-names>C</given-names></name><name><surname>Ibarra-Soria</surname><given-names>X</given-names></name><name><surname>Tyser</surname><given-names>RCV</given-names></name><name><surname>Ho</surname><given-names>DLL</given-names></name><name><surname>Reik</surname><given-names>W</given-names></name><name><surname>Srinivas</surname><given-names>S</given-names></name><name><surname>Simons</surname><given-names>BD</given-names></name><name><surname>Nichols</surname><given-names>J</given-names></name><name><surname>Marioni</surname><given-names>JC</given-names></name><name><surname>Göttgens</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A single-cell molecular map of mouse gastrulation and early organogenesis</article-title><source>Nature</source><volume>566</volume><fpage>490</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-0933-9</pub-id><pub-id pub-id-type="pmid">30787436</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramachandran</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Bardenhagen</surname><given-names>AE</given-names></name><name><surname>Nasr</surname><given-names>T</given-names></name><name><surname>Yates</surname><given-names>ER</given-names></name><name><surname>Zorn</surname><given-names>AM</given-names></name><name><surname>Ji</surname><given-names>H</given-names></name><name><surname>Vokes</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Hedgehog regulation of epithelial cell state and morphogenesis in the larynx</article-title><source>eLife</source><volume>11</volume><elocation-id>e77055</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.77055</pub-id><pub-id pub-id-type="pmid">36398878</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Revest</surname><given-names>JM</given-names></name><name><surname>Suniara</surname><given-names>RK</given-names></name><name><surname>Kerr</surname><given-names>K</given-names></name><name><surname>Owen</surname><given-names>JJ</given-names></name><name><surname>Dickson</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Development of the thymus requires signaling through the fibroblast growth factor receptor R2-IIIb</article-title><source>Journal of Immunology</source><volume>167</volume><fpage>1954</fpage><lpage>1961</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.167.4.1954</pub-id><pub-id pub-id-type="pmid">11489975</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheibner</surname><given-names>K</given-names></name><name><surname>Schirge</surname><given-names>S</given-names></name><name><surname>Burtscher</surname><given-names>I</given-names></name><name><surname>Büttner</surname><given-names>M</given-names></name><name><surname>Sterr</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Böttcher</surname><given-names>A</given-names></name><name><surname>Ansarullah</surname><given-names>M</given-names></name><name><surname>Beckers</surname><given-names>J</given-names></name><name><surname>Cernilogar</surname><given-names>FM</given-names></name><name><surname>Schotta</surname><given-names>G</given-names></name><name><surname>Theis</surname><given-names>FJ</given-names></name><name><surname>Lickert</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Publisher Correction: Epithelial cell plasticity drives endoderm formation during gastrulation</article-title><source>Nature Cell Biology</source><volume>23</volume><fpage>692</fpage><lpage>703</lpage><pub-id pub-id-type="doi">10.1038/s41556-021-00735-5</pub-id><pub-id pub-id-type="pmid">34294885</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sekine</surname><given-names>K</given-names></name><name><surname>Ohuchi</surname><given-names>H</given-names></name><name><surname>Fujiwara</surname><given-names>M</given-names></name><name><surname>Yamasaki</surname><given-names>M</given-names></name><name><surname>Yoshizawa</surname><given-names>T</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Yagishita</surname><given-names>N</given-names></name><name><surname>Matsui</surname><given-names>D</given-names></name><name><surname>Koga</surname><given-names>Y</given-names></name><name><surname>Itoh</surname><given-names>N</given-names></name><name><surname>Kato</surname><given-names>S</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Fgf10 is essential for limb and lung formation</article-title><source>Nature Genetics</source><volume>21</volume><fpage>138</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1038/5096</pub-id><pub-id pub-id-type="pmid">9916808</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stone</surname><given-names>KC</given-names></name><name><surname>Mercer</surname><given-names>RR</given-names></name><name><surname>Gehr</surname><given-names>P</given-names></name><name><surname>Stockstill</surname><given-names>B</given-names></name><name><surname>Crapo</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Allometric relationships of cell numbers and size in the mammalian lung</article-title><source>American Journal of Respiratory Cell and Molecular Biology</source><volume>6</volume><fpage>235</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.1165/ajrcmb/6.2.235</pub-id><pub-id pub-id-type="pmid">1540387</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tada</surname><given-names>S</given-names></name><name><surname>Era</surname><given-names>T</given-names></name><name><surname>Furusawa</surname><given-names>C</given-names></name><name><surname>Sakurai</surname><given-names>H</given-names></name><name><surname>Nishikawa</surname><given-names>S</given-names></name><name><surname>Kinoshita</surname><given-names>M</given-names></name><name><surname>Nakao</surname><given-names>K</given-names></name><name><surname>Chiba</surname><given-names>T</given-names></name><name><surname>Nishikawa</surname><given-names>SI</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Characterization of mesendoderm: a diverging point of the definitive endoderm and mesoderm in embryonic stem cell differentiation culture</article-title><source>Development</source><volume>132</volume><fpage>4363</fpage><lpage>4374</lpage><pub-id pub-id-type="doi">10.1242/dev.02005</pub-id><pub-id pub-id-type="pmid">16141227</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Hurd</surname><given-names>L</given-names></name><name><surname>Hannenhalli</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Lu</surname><given-names>MM</given-names></name><name><surname>Morrisey</surname><given-names>EE</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Regulation of lung endoderm progenitor cell behavior by miR302/367</article-title><source>Development</source><volume>138</volume><fpage>1235</fpage><lpage>1245</lpage><pub-id pub-id-type="doi">10.1242/dev.061762</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>L</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Garcia</surname><given-names>IM</given-names></name><name><surname>Chen</surname><given-names>HJ</given-names></name><name><surname>Castaldi</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>YW</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Human pluripotent stem cell-derived lung organoids: potential applications in development and disease modeling</article-title><source>Wiley Interdisciplinary Reviews. Developmental Biology</source><volume>10</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1002/wdev.399</pub-id><pub-id pub-id-type="pmid">33145915</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Travaglini</surname><given-names>KJ</given-names></name><name><surname>Nabhan</surname><given-names>AN</given-names></name><name><surname>Penland</surname><given-names>L</given-names></name><name><surname>Sinha</surname><given-names>R</given-names></name><name><surname>Gillich</surname><given-names>A</given-names></name><name><surname>Sit</surname><given-names>RV</given-names></name><name><surname>Chang</surname><given-names>S</given-names></name><name><surname>Conley</surname><given-names>SD</given-names></name><name><surname>Mori</surname><given-names>Y</given-names></name><name><surname>Seita</surname><given-names>J</given-names></name><name><surname>Berry</surname><given-names>GJ</given-names></name><name><surname>Shrager</surname><given-names>JB</given-names></name><name><surname>Metzger</surname><given-names>RJ</given-names></name><name><surname>Kuo</surname><given-names>CS</given-names></name><name><surname>Neff</surname><given-names>N</given-names></name><name><surname>Weissman</surname><given-names>IL</given-names></name><name><surname>Quake</surname><given-names>SR</given-names></name><name><surname>Krasnow</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A molecular cell atlas of the human lung from single-cell RNA sequencing</article-title><source>Nature</source><volume>587</volume><fpage>619</fpage><lpage>625</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2922-4</pub-id><pub-id pub-id-type="pmid">33208946</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Usui</surname><given-names>J</given-names></name><name><surname>Kobayashi</surname><given-names>T</given-names></name><name><surname>Yamaguchi</surname><given-names>T</given-names></name><name><surname>Knisely</surname><given-names>AS</given-names></name><name><surname>Nishinakamura</surname><given-names>R</given-names></name><name><surname>Nakauchi</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Generation of kidney from pluripotent stem cells via blastocyst complementation</article-title><source>The American Journal of Pathology</source><volume>180</volume><fpage>2417</fpage><lpage>2426</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2012.03.007</pub-id><pub-id pub-id-type="pmid">22507837</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wan</surname><given-names>H</given-names></name><name><surname>Kaestner</surname><given-names>KH</given-names></name><name><surname>Ang</surname><given-names>SL</given-names></name><name><surname>Ikegami</surname><given-names>M</given-names></name><name><surname>Finkelman</surname><given-names>FD</given-names></name><name><surname>Stahlman</surname><given-names>MT</given-names></name><name><surname>Fulkerson</surname><given-names>PC</given-names></name><name><surname>Rothenberg</surname><given-names>ME</given-names></name><name><surname>Whitsett</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Foxa2 regulates alveolarization and goblet cell hyperplasia</article-title><source>Development</source><volume>131</volume><fpage>953</fpage><lpage>964</lpage><pub-id pub-id-type="doi">10.1242/dev.00966</pub-id><pub-id pub-id-type="pmid">14757645</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Bioartificial Organ Manufacturing Technologies</article-title><source>Cell Transplantation</source><volume>28</volume><fpage>5</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1177/0963689718809918</pub-id><pub-id pub-id-type="pmid">30477315</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weaver</surname><given-names>M</given-names></name><name><surname>Yingling</surname><given-names>JM</given-names></name><name><surname>Dunn</surname><given-names>NR</given-names></name><name><surname>Bellusci</surname><given-names>S</given-names></name><name><surname>Hogan</surname><given-names>BL</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Bmp signaling regulates proximal-distal differentiation of endoderm in mouse lung development</article-title><source>Development</source><volume>126</volume><fpage>4005</fpage><lpage>4015</lpage><pub-id pub-id-type="doi">10.1242/dev.126.18.4005</pub-id><pub-id pub-id-type="pmid">10457010</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>E</given-names></name><name><surname>Ustiyan</surname><given-names>V</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Guo</surname><given-names>M</given-names></name><name><surname>Na</surname><given-names>CL</given-names></name><name><surname>Kalin</surname><given-names>GT</given-names></name><name><surname>Galvan</surname><given-names>V</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Weaver</surname><given-names>TE</given-names></name><name><surname>Kalin</surname><given-names>TV</given-names></name><name><surname>Whitsett</surname><given-names>JA</given-names></name><name><surname>Kalinichenko</surname><given-names>VV</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>In vivo generation of lung and thyroid tissues from embryonic stem cells using blastocyst complementation</article-title><source>American Journal of Respiratory and Critical Care Medicine</source><volume>203</volume><fpage>471</fpage><lpage>483</lpage><pub-id pub-id-type="doi">10.1164/rccm.201909-1836OC</pub-id><pub-id pub-id-type="pmid">32877203</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xing</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Hu</surname><given-names>L</given-names></name><name><surname>Tiozzo</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Chai</surname><given-names>Y</given-names></name><name><surname>Bellusci</surname><given-names>S</given-names></name><name><surname>Anderson</surname><given-names>S</given-names></name><name><surname>Minoo</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Mechanisms of TGFβ inhibition of LUNG endodermal morphogenesis: The role of TβRII, Smads, Nkx2.1 and Pten</article-title><source>Developmental Biology</source><volume>320</volume><fpage>340</fpage><lpage>350</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2008.04.044</pub-id><pub-id pub-id-type="pmid">18602626</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamaguchi</surname><given-names>T</given-names></name><name><surname>Sato</surname><given-names>H</given-names></name><name><surname>Kato-Itoh</surname><given-names>M</given-names></name><name><surname>Goto</surname><given-names>T</given-names></name><name><surname>Hara</surname><given-names>H</given-names></name><name><surname>Sanbo</surname><given-names>M</given-names></name><name><surname>Mizuno</surname><given-names>N</given-names></name><name><surname>Kobayashi</surname><given-names>T</given-names></name><name><surname>Yanagida</surname><given-names>A</given-names></name><name><surname>Umino</surname><given-names>A</given-names></name><name><surname>Ota</surname><given-names>Y</given-names></name><name><surname>Hamanaka</surname><given-names>S</given-names></name><name><surname>Masaki</surname><given-names>H</given-names></name><name><surname>Rashid</surname><given-names>ST</given-names></name><name><surname>Hirabayashi</surname><given-names>M</given-names></name><name><surname>Nakauchi</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Interspecies organogenesis generates autologous functional islets</article-title><source>Nature</source><volume>542</volume><fpage>191</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1038/nature21070</pub-id><pub-id pub-id-type="pmid">28117444</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamazaki</surname><given-names>K</given-names></name><name><surname>Kubara</surname><given-names>K</given-names></name><name><surname>Ishii</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Dairiki</surname><given-names>R</given-names></name><name><surname>Hihara</surname><given-names>T</given-names></name><name><surname>Ishizuka</surname><given-names>Y</given-names></name><name><surname>Izumi</surname><given-names>Y</given-names></name><name><surname>Kumai</surname><given-names>M</given-names></name><name><surname>Kamisako</surname><given-names>T</given-names></name><name><surname>Ishizaki</surname><given-names>H</given-names></name><name><surname>Sato</surname><given-names>H</given-names></name><name><surname>Masaki</surname><given-names>H</given-names></name><name><surname>Mizuno</surname><given-names>N</given-names></name><name><surname>Mitsuhashi</surname><given-names>K</given-names></name><name><surname>Ito</surname><given-names>M</given-names></name><name><surname>Hamanaka</surname><given-names>S</given-names></name><name><surname>Yamaguchi</surname><given-names>T</given-names></name><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Sugiyama</surname><given-names>F</given-names></name><name><surname>Nakauchi</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>In vitro and in vivo functions of T cells produced in complemented thymi of chimeric mice generated by blastocyst complementation</article-title><source>Scientific Reports</source><volume>12</volume><elocation-id>3242</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-022-07159-7</pub-id><pub-id pub-id-type="pmid">35217706</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>Y</given-names></name><name><surname>White</surname><given-names>AC</given-names></name><name><surname>Huh</surname><given-names>SH</given-names></name><name><surname>Hilton</surname><given-names>MJ</given-names></name><name><surname>Kanazawa</surname><given-names>H</given-names></name><name><surname>Long</surname><given-names>F</given-names></name><name><surname>Ornitz</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>An FGF–WNT gene regulatory network controls lung mesenchyme development</article-title><source>Developmental Biology</source><volume>319</volume><fpage>426</fpage><lpage>436</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2008.04.009</pub-id><pub-id pub-id-type="pmid">18533146</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yokomizo</surname><given-names>T</given-names></name><name><surname>Ideue</surname><given-names>T</given-names></name><name><surname>Morino-Koga</surname><given-names>S</given-names></name><name><surname>Tham</surname><given-names>CY</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Takeda</surname><given-names>N</given-names></name><name><surname>Kubota</surname><given-names>Y</given-names></name><name><surname>Kurokawa</surname><given-names>M</given-names></name><name><surname>Komatsu</surname><given-names>N</given-names></name><name><surname>Ogawa</surname><given-names>M</given-names></name><name><surname>Araki</surname><given-names>K</given-names></name><name><surname>Osato</surname><given-names>M</given-names></name><name><surname>Suda</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Independent origins of fetal liver haematopoietic stem and progenitor cells</article-title><source>Nature</source><volume>609</volume><fpage>779</fpage><lpage>784</lpage><pub-id pub-id-type="doi">10.1038/s41586-022-05203-0</pub-id><pub-id pub-id-type="pmid">36104564</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.86105.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Morrisey</surname><given-names>Edward E</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00b30xv10</institution-id><institution>University of Pennsylvania</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.10.31.514628" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.10.31.514628"/></front-stub><body><p>This study clearly shows the ability to generate whole lungs using a blastocyst complementation assay. The work elegantly uses a Foxa2 deficient by ground to promote generation of lungs from a Foxa2 replete donor. These findings will spur further interest in xenotransplantation approaches for human organs.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.86105.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Morrisey</surname><given-names>Edward E</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00b30xv10</institution-id><institution>University of Pennsylvania</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.10.31.514628">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.10.31.514628v4">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Conditional blastocyst complementation of a defective Foxa2 lineage efficiently promotes generation of the whole lung&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1) Please provide additional data to better reveal the contribution of Foxa2 lineage-labeled Pdgfra+ cells to early mesoderm.</p><p>2) Please provide additional data to illustrate the heterogeneity of the cell types in the reported culture systems.</p><p>3) Provide quantitation of lineage tracing experiments as outlined by reviewer #2.</p><p>4) Provide an additional explanation of the uniqueness of this lung agenesis model as compared to previously reported models i.e. <italic>Fgfr2</italic> null.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>1) The authors use the term bona fide lung generative lineage (BFL) throughout the manuscript. However, the data do not support the concept as such, it should be either be removed or rephrased.</p><p>2) The authors state (line 147-148) that the &quot;Foxa2 lineage-labeled Pdgfra+ cells ingress from the primitive streak to the nascent mesoderm regions&quot;, providing the data shown in Figure 1D as evidence. While it seems reasonable to conclude that this is the case, a single static confocal image isn't sufficient data upon which to draw this conclusion.</p><p>3) In Figure 3B, the authors highlight &quot;distal lung bud epithelium&quot;. While the Nkx2.1+ cells do also appear to express <italic>SOX9</italic>, the majority of <italic>SOX9</italic>+ cells in the culture do not appear to express <italic>SOX9</italic>. This should be clarified. Are most of the <italic>SOX9</italic>-expressing cells in this culture system in fact mesenchyme, which only small clusters of Nkx2.1+/<italic>Sox9</italic>+ lung epithelium?</p><p>4) The authors should more explicitly outline how blastocyst complementation using the current knockout mouse model (Foxa2-Cre; <italic>Fgfr2</italic> fl/fl) significantly adds to the existing body of literature where blastocyst complementation has already been performed in mice with a severe lung hypoplasia or agenesis phenotype (Nkx2.1-/-, Fgf10-/-, conditional epithelial-specific ablation of Ctnnb1 or <italic>Fgfr2</italic>).</p><p>5) In Figures 4D and Tables 1-2 blastocyst complementation following conditional loss of <italic>Fgfr2</italic> with either the Foxa2-Cre or Shh-Cre are compared, but no statistics are provided. Specifically, the authors claim that in contrast to the Shh-Cre animals, in the Foxa2-Cre mice that &quot;almost the entire lung epithelial, mesenchymal and endothelial cells populations at E17.5 was composed exclusively of nGFP+iPSCs&quot;. However, the numbers provided don't seem to support this claim. For example, just looking at the mesenchyme Foxa2-Cre (92.6, 90, 89.8, 87.3, 57.6) versus Shh-Cre (71.7, 76.5). While it is true that the mean percentage is slightly higher in the Foxa2 mice, although the mean is in fact slightly higher (83.5% versus 74.1%), this is both not statistically significant and even if it was, a relatively small difference given that it is a major claim being made to support the significance of the findings. These data need to be expanded and clarified, particularly in relation to the previous comment (#4).</p><p>6) It is interesting that despite the lung agenesis phenotype, the other organs appear to be relatively spared (Supplemental Figure 2). It would be interesting to explore this further.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>The conclusions of this paper are mostly well supported by data, but some aspects of data analysis need to be clarified and extended.</p><p>1). Figure 4D showed that ~20% of mesenchyme and endothelium cells are still derived from host cells, it will be interesting for authors to investigate whether host cells contribute to certain types of mesenchyme and endothelium cells or random contributed.</p><p>2). For figure 1B, the text describes Pdgfrb+ pulmonary mesenchyme, however, the figure show Pdgfra staining.</p><p>3). The author should discuss the reason that they did not observe agenesis phenotype in other major internal organs in Foxa2-driven <italic>Fgfr2</italic>-deficient mice.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.86105.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) Please provide additional data to better reveal the contribution of Foxa2 lineage-labeled Pdgfra+ cells to early mesoderm.</p></disp-quote><p>We performed additional IF (immunofluorescent)-confocal morphometric analyses at the primitive streak (PS) stage to better reveal the contribution of Foxa2 lineage-labeled Pdgfra+ cells to early mesoderm. We found that 80% of gastrulating PS cells expressed Pdgfra protein expression, of which about 20% were co-labeled with tdTomato+ Foxa2 lineage. This proportion is nearly the same proportion of E14.5 Foxa2-lineage labeled cells in lung mesenchyme. This indicates that lung mesenchyme precursor marked by Foxa2-linage+ Pdgfra+ cells originates mid-streak during gastrulation before the lateral plate mesoderm (LPM) formation. These data were added in the new Figure 1F, and 1G and the manuscript lines 156-162.</p><disp-quote content-type="editor-comment"><p>2) Please provide additional data to illustrate the heterogeneity of the cell types in the reported culture systems.</p></disp-quote><p>We additionally performed IF morphometric analyses across the time point to reveal better the cell heterogeneity of lung progenitors and precursors in the human lung-directed differentiation protocol. To reflect this finding of the heterogeneity of lung progenitors based on the morphometric analyses, we replaced Figure 3C with the new Figure 3 —figure supplement 1 and described it in the manuscript, lines 221-230.</p><p>It showed that NKX2-1+ cells preceded to appear on the bud-like structure on day 6 and followed by the <italic>Sox9</italic> expression. On day 15, most budding cells turned on NKX2-1 and <italic>SOX9</italic>. Further morphometric analyses also found that non-budding lung progenitors gradually turned on TBX4, and about 50% of the non-budding cells expressed TBX4, which made the heterogeneity of lung progenitors. Non-TBX4 positive cells are possibly lung progenitors that do not express TBX4 yet or another cell type. This finding was added in new Figure 3 —figure supplement 1 and the manuscript, lines 221-230.</p><disp-quote content-type="editor-comment"><p>3) Provide quantitation of lineage tracing experiments as outlined by reviewer #2.</p></disp-quote><p>We quantified the lineage-tracing results by morphometric analyses described in Figures 1C and 1G. We provided the quantification of Foxa2 lineage tracing studies in early embryogenesis and removed the unqualified results from Figure 1 (Figure 1F and 1G and Figure 1C), and the manuscript was corrected in lines 136-144 and 154-162.</p><p>Regarding Figure 1C, we have tried to have more numbers of embryos for these analyses using Pdgfra<sup>CreERT2</sup>; Rosa <sup>tdTomato/+</sup> mice. However, we often encountered embryo miscarriage due to the effect of Tamoxifen, even with the titration of tamoxifen or using the co-injection of progesterone (Nikita et al., 2019). Through more than twenty times experimental trials of Tm injection, we finally obtained a total of four embryos, three at E12.5 and one at E14.5.</p><p>E14.5 lung immunostaining analysis showed that the entire lung mesenchyme was labeled with tdTomato but not much in the epithelium (Figure 1A). Two E12.5 lungs showed entire labeling of tdTomato, but one embryo showed around 50% labeling in the mesenchyme and no labeling in the epithelium. We thought that this was because of the short time window of Pdgfra expression during gastrulation. This result corresponds to directed differentiation using human iPSC and the deposited scRNAseq analyses described in Figure 5—figure supplement1A; Pdgfra temporally expressed during gastrulation but not spontaneously expressed in the later stage. This data was outlined in the manuscript, lines 136-144.</p><disp-quote content-type="editor-comment"><p>4) Provide an additional explanation of the uniqueness of this lung agenesis model as compared to previously reported models i.e. Fgfr2 null.</p></disp-quote><p>With this constructive suggestion from the reviewers, we extensively analyzed the lungs and other organs. This approach led us to discover the novel insights of this model (see the following points), lacking in the Shh-based CBC model.</p><p>1. We also increased the number of N of the biological replicates for the flow cytometry analyses in comparing the Shh and Foxa2-based CBC models. Although there is a clear tendency of the increased complementation proportion in the Foxa2 model than Shh models as described in the new Figure 4D-4E and Figure 4—figure supplement 3C-3D, we could not have the statistical significance. Thus, we quantified the chimerism with mesenchyme markers by morphometric analyses in the chimeric lungs of the Shh vs. Foxa2 -based CBC model. It revealed that the chimerism in Sma+ airway smooth muscle cells, CD31+ capillary, and NG2+ pericyte showed significantly higher chimerism in the Foxa2 model compared to the Shh model. This data was included in the new Figure 4F-H and Figure 4—figure supplement 4 – outlined in the manuscript, lines 295-300.</p><p>2. We found that the knockout model analysis of Foxa2<sup>Cre/+</sup>; Fgfr2<sup>cnull</sup> showed shorter trachea compared to Shh<sup>Cre/+</sup>; Fgfr2<sup>cnull</sup> trachea. Foxa2<sup>Cre/+</sup>; Fgfr2<sup>cnull</sup> showed truncated trachea in the middle of thoracic cavity all the time and all the time stopped elongation above the aortic arch, meantime Shh<sup>Cre/+</sup>; Fgfr2<sup>cnull</sup> showed entire trachea and truncated in the middle of the bronchus. This severe malformation phenocopies the Fgf10 knockout mice. This could be due to the distinct lineage labeling of Shh and Foxa2 during primordial lung formation. Further investigation is required in future studies. When we analyzed the chimerism in the tracheal epithelium of Foxa2<sup>Cre/+</sup>; Fgfr2<sup>cnull</sup> injected with donor cells, significantly higher chimerism in the tracheal epithelium but not in the tracheal mesenchyme, this result is included in Figure 4—figure supplement 5 and outlined in the manuscript, lines 300-304.</p><p>3. We accidentally found that Foxa2<sup>Cre/+</sup>; Fgfr2<sup>cnull</sup> showed thymus agenesis phenotype as described in the new Figure 4 —figure supplement 2, but not in Shh<sup>Cre/+</sup>; Fgfr2<sup>cnull</sup>. <italic>Fgfr2</italic> is known to be necessary for thymus formation (Dooley et al., 2007). When we analyzed chimerism in the thymic epithelium, Foxa2<sup>Cre/+</sup>; Fgfr2<sup>cnull</sup> injected with donor cells showed significantly higher chimerism. These new findings and discussion were included in Figure 4 —figure supplement 2, and the significance was described in the manuscript, lines 307-313 and 431-456.</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>1) The authors use the term bona fide lung generative lineage (BFL) throughout the manuscript. However, the data do not support the concept as such, it should be either be removed or rephrased.</p></disp-quote><p>We deleted the BFL concept and the sentences from the entire manuscript.</p><disp-quote content-type="editor-comment"><p>2) The authors state (line 147-148) that the &quot;Foxa2 lineage-labeled Pdgfra+ cells ingress from the primitive streak to the nascent mesoderm regions&quot;, providing the data shown in Figure 1D as evidence. While it seems reasonable to conclude that this is the case, a single static confocal image isn't sufficient data upon which to draw this conclusion.</p></disp-quote><p>We deleted the description, and we showed the additional evidence with the quantification results in Figure 1E-1G outlined in the manuscript of lines 154-162.</p><disp-quote content-type="editor-comment"><p>3) In Figure 3B, the authors highlight &quot;distal lung bud epithelium&quot;. While the Nkx2.1+ cells do also appear to express SOX9, the majority of SOX9+ cells in the culture do not appear to express SOX9. This should be clarified. Are most of the SOX9-expressing cells in this culture system in fact mesenchyme, which only small clusters of Nkx2.1+/Sox9+ lung epithelium?</p></disp-quote><p>The previous image did not explain well the directed differentiation heterogeneity. Therefore, we performed time course IF analyses and their quantification by morphometric analyses for the directed differentiation. It was described in Figure 3 —figure supplement 1 and outlined in the manuscript of lines 215-229. In the middle of differentiation, bud structure appeared in the culture dish. Those NKX2-1 and <italic>SOX9</italic> expression patterns were initially random around days 6~8 and mosaic but later homogenously expressed both NKX2-1 and <italic>SOX9</italic> around days 14~15. To reflect this finding of the heterogeneity of lung progenitors based on the morphometric analyses, we replaced Figure 3B.</p><disp-quote content-type="editor-comment"><p>4) The authors should more explicitly outline how blastocyst complementation using the current knockout mouse model (Foxa2-Cre; Fgfr2 fl/fl) significantly adds to the existing body of literature where blastocyst complementation has already been performed in mice with a severe lung hypoplasia or agenesis phenotype (Nkx2.1-/-, Fgf10-/-, conditional epithelial-specific ablation of Ctnnb1 or Fgfr2).</p></disp-quote><p>Our new Foxa2-lineage-based CBC model mice showed novel evidence of the co-generation of lung and thymus. We also added evidence that those rescued mice of the Foxa2-lineage-based CBC model survived until adulthood with normal lung function. Furthermore, our overall analyses showed relatively high efficacy of functional lung complementation in adults than the previous reports (see Supplementary File 3). All of this evidence was not shown in the previous complementation method.</p><disp-quote content-type="editor-comment"><p>5) In Figures 4D and Tables 1-2 blastocyst complementation following conditional loss of Fgfr2 with either the Foxa2-Cre or Shh-Cre are compared, but no statistics are provided. Specifically, the authors claim that in contrast to the Shh-Cre animals, in the Foxa2-Cre mice that &quot;almost the entire lung epithelial, mesenchymal and endothelial cells populations at E17.5 was composed exclusively of nGFP+iPSCs&quot;. However, the numbers provided don't seem to support this claim. For example, just looking at the mesenchyme Foxa2-Cre (92.6, 90, 89.8, 87.3, 57.6) versus Shh-Cre (71.7, 76.5). While it is true that the mean percentage is slightly higher in the Foxa2 mice, although the mean is in fact slightly higher (83.5% versus 74.1%), this is both not statistically significant and even if it was, a relatively small difference given that it is a major claim being made to support the significance of the findings. These data need to be expanded and clarified, particularly in relation to the previous comment (#4).</p></disp-quote><p>We extended the analysis of the complemented lungs with an increased number of N (biological replicates). In flow cytometry data analyses, we still did not observe the statistical significance yet, while we observed the tendency of the higher proportion of complementation in the Foxa2-lineage-based CBC model. Therefore, we quantified the lung mesenchyme complementation by the IF morphometric analyses. It revealed that the chimerism in Sma+ airway smooth muscle cells, CD31+ capillary, and NG2+ pericyte showed significantly higher chimerism in the Foxa2 model compared to the Shh model. We included this data in Figures 4F-H and Figures 4—figure supplement 4, and the manuscript of lines 288-293. As described above, we also added novel evidence of the co-generation of the lung and thymus, which was not defined in the previous papers.</p><disp-quote content-type="editor-comment"><p>6) It is interesting that despite the lung agenesis phenotype, the other organs appear to be relatively spared (Supplemental Figure 2). It would be interesting to explore this further.</p></disp-quote><p>As described above, we included the analysis of Foxa2<sup>Cre/+</sup>; Fgfr2<sup>cnull</sup> phenotype in new Figures 4 —figure supplement 1C and 2A outlined in the manuscript, lines 266-276.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>The conclusions of this paper are mostly well supported by data, but some aspects of data analysis need to be clarified and extended.</p><p>1). Figure 4D showed that ~20% of mesenchyme and endothelium cells are still derived from host cells, it will be interesting for authors to investigate whether host cells contribute to certain types of mesenchyme and endothelium cells or random contributed.</p></disp-quote><p>We further analyzed the chimerism based on cell types and found that Sma+ airway smooth muscle, Pecam+ capillary, and NG2+ pericyte showed higher contributions from injected donor cells. The results were included in Figures 4F-H and Figures 4—figure supplement 4 and in the manuscript lines 295-300.</p><disp-quote content-type="editor-comment"><p>2). For figure 1B, the text describes Pdgfrb+ pulmonary mesenchyme, however, the figure show Pdgfra staining.</p></disp-quote><p>We apologize for the careless mistake. We corrected the term described in the manuscript line 140.</p><disp-quote content-type="editor-comment"><p>3). The author should discuss the reason that they did not observe agenesis phenotype in other major internal organs in Foxa2-driven Fgfr2-deficient mice.</p></disp-quote><p>This phenotype was based on the combination of Cre driver and <italic>Fgfr2</italic> necessity for organ development. We included this discussion in the manuscript lines 399-404.</p></body></sub-article></article>